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THE ROLE OF PESTICIDES IN NON-ALCOHOLIC FATTY 




April 03, 2014 
 
NAFLD, the most common form of liver disease worldwide, is caused by 
various factors including industrial chemicals and pesticides exposure. Annually, 
5.2 billion pounds of pesticides are used worldwide and can contribute to liver 
disease, but their role is modestly studied. We hypothesize that pesticides 
contaminating food supply can worsen diet-induced steatosis via xenobiotic 
receptor activation. Two human and two rodent databases were utilized and 85% 
of the 330 chemicals identified associated with NAFLD were pesticides. Eight 
were selected for evaluating hepatic receptor activation in vitro. The majority 
including DDT activated hPXR/CAR and mPXR. DDT (100 mg/kg) was studied in 
vivo in a diet-induced obesity (DIO) model. DDT upregulated Cyp2b10 (CAR 
target) in control diet-fed mice. DDT decreased adiposity, but it did not affect 
weight gain, food consumption or insulin resistance. In conclusion, DDT 
improved steatosis, but it did not affect NAFLD, obesity, liver damage or diabetes 
caused by DIO. 
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In our daily lives, we are exposed to a variety of chemicals, many of which 
are pesticides, through food consumption or contact with skin and air. According 
to the United States Environmental Protection Agency (US EPA), a pesticide is 
defined as "any substance or mixture of substances intended for preventing, 
destroying, repelling, or mitigating any pest”. Although pesticides are often 
restricted to insecticides, the term ‘pesticide’ also applies to herbicides, 
fungicides, and various other substances used for controlling pests (1). Pesticide 
usage is a double-edged sword; they are valuable for controlling pests, but they 
are also poisonous compounds to humans and animals. Many of these 
compounds are lipophilic and tend to accumulate in the adipose tissue. However, 
the body defense mechanism, particularly the liver, is responsible for the 
detoxification of these xenobiotic compounds through metabolism by cytochrome 
P450 enzymes, including CYP3A and CYP2B families (2, 3). In contrast, if the 
pesticides’ bioaccumulated concentration reaches lethal levels due to high dose 
or chronic exposure, they can overwhelm the liver detoxification capacity and 
cause toxicity. In fact, the WHO reported that at least 3 million cases of pesticide 
poisoning occur worldwide annually. Furthermore, many pesticides have been 
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associated with liver disease and elevated levels of liver enzymes 
(aminotransferases) (4).  
Chemical pesticides are classified into four main classes: 
organophosphate, carbamate, organochlorine and pyrethroid pesticides (5). Our 
laboratory works with persistent organic pollutants (POPs) including 
polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCPs) and 
their association with liver disease. Epidemiological studies have demonstrated 
associations between pesticides such as OCPs and toxicant associated 
steatohepatitis (TASH)/nonalcoholic fatty liver disease (NAFLD) as well as serum 
alanine aminotransferase (ALT) elevation (6). However, the mechanisms by 
which these compounds potentiate liver disease and damage are poorly studied. 
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent form of 
liver disease worldwide (7-9). It is often associated with obesity, insulin 
resistance, diabetes and other metabolic disorders primarily through adipo-
cytokine dysregulation and hence, NAFLD is considered a hepatic indicator of 
the metabolic syndrome (10, 11). Histopathologically, NAFLD involves a wide 
spectrum of liver damage, initiating from steatosis, which is characterized by fatty 
liver, and transforming to steatohepatitis (12, 13). Our laboratory focuses 
specifically on nonalcoholic steatohepatitis (NASH), which progresses in a “two 
hit” model (8). The first hit results in steatosis, an accumulation of macrovesicular 
or microvesicular triglyceride in at least 5% of hepatic cells, and this can be 
brought about by excessive consumption of hyper-caloric diets such as high-
fructose diet (9, 14, 15). The “second hit” results in hepatic and systemic 
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inflammation which is accompanied by increased levels of inflammatory 
cytokines/adipokines, mitochondrial dysfunction and oxidative stress and causes 
steatohepatitis and fibrosis (13, 16). Steatohepatitis may then progress to fibrosis 
and cirrhosis (4). The “second hit” can include factors such as industrial 
chemicals and toxic pollutants leading to the term “toxicant associated 
steatohepatitis” (TASH) (17, 18). We focus on the role of environmental 
pollutants as a ‘second hit’ in NAFLD and the mechanisms of their action in the 
potentiation and progression of steatohepatitis.  
TASH was first described in vinyl chloride (VC) workers who reported 
increased levels of proinflammatory cytokines, insulin resistance, and antioxidant 
depletion (17, 18). The necrotic hepatocyte death biomarker, cytokeratin 18, was 
also elevated in these workers (11, 19). Mild to moderate ALT and aspartate 
aminotransferase (AST) elevation are the only laboratory manifestations reported 
in most cases of steatohepatitis (14, 18, 20, 21). However, the VC workers with 
TASH had normal serum ALT and AST levels. On the other hand, abnormalities 
in ALT and AST levels have been reported in humans and animals exposed to 
other chemicals such as carbon tetrachloride, dimethylformamide, some minerals 
and pesticides (22).  
Xenobiotic compounds are metabolized by P450 enzymes, which are 
under the control of xenobiotic receptors, and this metabolic link can add a layer 
of complexity to both the disease and treatment state. Hepatic xenobiotic 
receptors, particularly the pregnane xenobiotic receptor (PXR) and the 
constitutive androstane receptor (CAR), play an important role in xenobiotic 
	   4	  
metabolism. Apart from regulating detoxification, PXR has been reported to 
promote lipogenesis and repress fatty acid-β-oxidation leading to hepatic lipid 
accumulation (23, 24). On the other hand, CAR reportedly suppresses 
gluconeogenesis and lipid metabolism and decreases serum triglyceride levels 
(24). Hence both PXR and CAR appear to play a pivotal role in regulating energy 
metabolism and their activation/inhibition can lead to NAFLD, obesity and the 
metabolic syndrome (24). In addition to CAR and PXR, other nuclear receptors 
such as the peroxisome proliferator-activated receptors (PPARs) regulate genes 
associated with glucose and lipid metabolism, adipogenesis, insulin sensitivity, 
cell growth, and differentiation (25, 26). Their activation also affects immune 
responses and energy homeostasis. In fact, PPARs are important therapeutic 
targets in treating metabolic disorders such as diabetes (25). The 
thiazolidinedione drugs, which are PPARγ agonists are used for treating type 2 
diabetes, whereas another type 2 drug, metformin, works via PPARα-dependent 
or independent mechanisms (26, 27). Similar to the PPARs, the farnesoid X 
receptor (FXR), plays an important role in regulating metabolism of bile acids, fat, 
cholesterol, glucose and xenobiotics (28). In fact, clinical trials on FXR-targeting 
drugs for treating cholestasis, type 2 diabetes mellitus, NASH or NAFLD and 
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Significance of The Study: 
Non-alcoholic fatty liver disease (NAFLD) is prevalent in 30% of the US 
adult population and it is the leading cause of chronic liver disease worldwide (7, 
8, 29). According to a community-based study, NAFLD increases the mortality 
risk among the US population (7). NAFLD was associated with obesity, insulin 
resistance, diabetes and other metabolic disorders (10, 11). In one study, 100% 
of obese diabetic patients had steatosis, 50% of those had steatohepatitis and 
19% had cirrhosis (30). Furthermore, many industrial chemicals including 
pesticides have been associated with fatty liver disease.  
Elevated serum ALT and AST are traditional biomarkers of NAFLD (4). 
Abnormalities in ALT and AST were found in humans and animals exposed to 
OCPs and other chemicals such as carbon tetrachloride, dimethylformamide, 
minerals and pesticides (4, 22). Because traditional NAFLD biomarkers are not 
effective in diagnosing TASH, liver biopsies serve as a good diagnostic tool. 
However, obtaining human liver biopsies can be challenging, therefore, animal 
models can be a valuable tool in identifying TASH-causing chemicals. 
Furthermore, the concentration(s) needed and mechanism(s) exhibited by   
pesticides in their contribution to NAFLD are modestly studied due to the lack of 
disease manifestations and chemical indicators. Additionally, a comprehensive 
list of these chemicals is not currently available in literature. 
Pesticide exposure and their biological effects are relevant because 
annual pesticide consumption worldwide was 5.2 billion pounds, out of which 1.1 
billion pounds was consumed in the US alone (31). While a large number of 
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pesticides have been banned in many countries including the US, some still exist 
in the environment due to their thermodynamic stability and lipophilicity.  
The hepatic xenobiotic receptors such as CAR and PXR play an important 
role in both xenobiotic detoxification and endobiotic metabolism either through 
direct activation or interaction with other receptors (24). Therefore, elucidating 
the mode(s) of action of pesticides through CAR and PXR regulation is crucial in 
terms of NAFLD due to their role in maintaining energy homeostasis (23, 24).  
Based on the evidence provided, we hypothesize that pesticides, which 
contaminate the food supply, may worsen diet-induced steatohepatitis via 
xenobiotic receptor activation, PXR and CAR. Therefore, to test our hypothesis, 
1) we identified pesticides associated with steatohepatitis and NAFLD in a) 
rodent studies (ToxRefDB and CEBS) and b) human studies (NHANES). 2) We 
identified pesticides activating PXR and CAR in humans a) via data-screening of 
ToxCastDB database and b) screening assays using HepG2 cells. 3) After 
screening a list of pesticides, which were associated with NAFLD and activated 
PXR and CAR, we selected DDT, a relevant POPs, to be studied in vivo in a diet-












IDENTIFICATION OF CHEMICALS ASSOCIATED WITH NAFLD 
INTRODUCTION 
 
The liver is the first-line of defense against potentially harmful xenobiotics, 
and it is therefore not surprising that it is also the target organ that is most 
commonly affected by industrial chemicals (4). Indeed, 33% of the 677 most 
common workplace chemicals reported in the National Institute of Occupational 
Safety and Health Pocket Guide are associated with hepatotoxicity (32). The 
pathologic liver lesions associated with chemical exposures are myriad and 
range from hepatitis to fibrosis and cirrhosis with liver cancer (22).  However, 
following the description of TASH, it now appears that fatty liver may be the most 
common pathologic response to chemicals (4, 20, 22, 33, 34).  
Recent terms describing fatty liver disease such as “steatosis” and 
“steatohepatitis” were not well-known before recognizing fatty liver disease as a 
clinical disease. Consequently, one of the tools used to identify compounds 
relevant to liver disease, is to search former chemical studies by looking at fatty 
liver clinical and histopathological biomarkers. With NAFLD, the only clinical 
biomarker for fatty liver disease is serum ALT elevation. However, diagnosing 
TASH in humans is challenging for several reasons, namely, the entity is 
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clinically under-recognized and routine clinical biomarkers are insensitive. Also, 
out of the 83 million substances and 65 million sequences registered by the 
chemical abstracts service by 2014, there is no comprehensive list of chemicals 
that cause TASH (35). As such, TASH is a clinicopathologic diagnosis that relies 
solely on histologic examination. 
The transition from steatosis to steatohepatitis is characterized by 
centrilobular (zone 3) centered injury and lobular inflammation (lymphocytes with 
neutrophils and activated Kupffer cells), hepatocyte ballooning and Mallory-Denk 
bodies and fibrosis (36). While these findings are typically present in hemotoxylin 
and eosin (H&E) stained slides, other stains such as Oil-Red-O that stains micro-
vesicular lipid droplets are used to quantify steatosis. Similar pathologic lesions 
have been observed in human NAFLD/TASH and in rodent models of 
steatohepatitis (4). 
The purpose of this part of the study is to identify chemicals associated 
with the development of hepatic steatosis in previously published human and 
rodent studies. Searchable archive of Human studies from the 2003-2004 
NHANES (National Center for Health Statistics) and rodent studies provided in 
the websites of US Environmental Protection agency (EPA) and the National 
Institute of Environmental Health Sciences (NIEHS) presented a unique 
opportunity to accomplish this objective. The identification of environmental 
chemicals associated with the development of hepatic steatosis/TASH will enable 
subsequent mechanistic animal studies and clinical translation in exposed 
humans. 
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MATERIALS AND METHODS 
 
Data-screening: 
The first database screened was the 2003–2004 National Health and 
Nutrition Examination Survey of the United States population (NHANES 2003–
2004). The NHANES was evaluated in a cross-sectional cohort study done 
previously by our group. The National Center for Health Statistics (NCHS) 
conducts the NHANES as a complex multistage probability sample, and 
interprets the health and nutrition findings as representative of the non-
institutionalized U.S. civilian population (37). Approval for the analysis of the 
NHANES data was granted by the University of Louisville Institutional Review 
Board. The following exclusion criteria were used in the study: age < 18 years, 
positive serum hepatitis B surface antigen, positive serum hepatitis C antibody, 
elevated transferrin saturation (> 60% for men and > 50% for women), and 
alcohol consumption ≥ 20 g/day for men and ≥ 10 g/day for women. As classified 
by the NCHS, the downloaded pollutants data posted prior to December 2008 
showed 196 pollutants from 17 subclasses (38). All alanine aminotransferase 
(ALT) and pollutant levels were measured for each participant and 111 of 196 
pollutants were evaluated (38). Elevated ALT was defined as proposed by Prati 
et al. (>30 IU/L for men and >19 IU/L for women) (38, 39). Subjects were 
classified into different quartiles for each class of pollutants, with the first quartile 
composed of subjects with the lowest serum levels of each pollutant. Pollutants 
within the same subclass were then summed by their ranks depending on the 
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magnitude of their detectable levels, because  of the likelihood of an individual’s 
exposure to more than one pollutant in the same subclass (38). Multivariate-
adjusted odds ratios for ALT elevation were measured though the increasing 
quartiles of chemical exposure and the 1st quartile was used as the reference 
group (38).  
Two more sets of rodent databases compiled by the federal government 
for environmental chemicals were used in this study. The former was the 
Environmental Protection Agency (EPA) database known as ToxRefDB or the 
Toxicological Reference Database, which was designed by the National Center 
for Computational Toxicology (NCCT) and Environmental Protection Agency’s 
(EPA) office of Pesticide programs (OPP). This database includes pesticide 
registration toxicity data for the past 30 years and $2 billion of animal studies 
results (40, 41). Using standardized vocabulary, ToxRefDB  warehouses detailed 
study design, dosing, and observed treatment-related effects (41). The 
ToxRefDB stores also chemical toxicity data in detail in free accessible and 
searchable databases (41). ToxRefDB also connects with the ACToR 
(Aggregated Computational Toxicology Resource) in order to link it with public 
hazard, exposure and risk resources (41). Furthermore, ToxRefDB  is connected 
to the ToxCast, another EPA chemical screening tool used to understand 
biological processes affected by chemicals (41). The available ToxRefDB 
database allows aggregation and grouping of chemicals depending on the 
toxicological outcomes that are specific to the type of the study and target 
organ/effect categories (e.g., tumorigenicity) (42). ToxRefDB classifies chemicals 
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by their relative potency depending on specific endpoints and also assigns 
groups based on the mechanism of action (42). Future improvements of the 
ToxRefDB are planned, which will connect the relational environment of 
ToxRefDB with associated chemical structure information (43). Furthermore, 
searching will develop predictive high-through-put screening bioactivity profiles 
and genomic signatures (16).  Currently, ToxRefDB warehouses searchable 
pathologic information on 474 studies of pesticides and intermediates. In our 
study, the 474 rat/mouse studies were queried for histological NAFLD and TASH 
descriptors including “fatty change”, “Oil red O positive”, “steatosis”, and “lipid 
deposition”. The data were accessed in Fall 2013 at 
http://actor.epa.gov/toxrefdb/faces/Home.jsp.  The following study types were 
queried: sub-chronic (SUB), chronic (CHR) and multigeneration reproductive 
(MGR) in both rat and mouse species. The effect type selected was “pathology 
(non-neoplastic)”. The effect target was always the “liver” in the search and the 
effect descriptions were: “fatty change”, “lipid deposition”, “steatosis” and “Oil red 
O” positivity in increased effect direction. Compound selection was based on the 
altered NAFLD and TASH descriptors at the Lowest Effect Level (LEL). 
Compounds and their LELs were arranged and listed in tables (Appx. 1).  
The latter rodent database was the Chemical Effects in Biological 
Systems (CEBS) data repository developed by the National Toxicology Program 
(NTP) and it warehouses about 9000 rodent toxicology studies (44). CEBS 
combines public toxicogenomics databases such as the study design and 
timeline, clinical chemistry and histopathology, microarray and proteomics data 
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(45). CEBS warehouses data from academic, industrial and governmental 
laboratories and it was mainly developed to allow public and free search though 
the results of these studies (45, 46). CEBS stores rats, mice and human subjects 
studies and it contains more than 4000 microarray hybridizations, and 75 2D gel 
images with details protein identification (45). Furthermore, CEBS contains the 
clinical chemistry and histopathology data from more than 1500 animals (45). 
CEBS was accessed at: http://cebs.niehs.nih.gov.  The queried assay domain 
was “histopathology” and the diagnoses selected were “fatty change” and “toxic 
hepatopathy” as the latter two terms appear to have been used to describe fatty 
liver in several National Toxicology Program  (NTP) reports on polychlorinated 
biphenyls (47). “Liver and all its parts” was always the target organ selected and 
all degrees of severity were included. The search initially returned 329 studies, 
but medications and natural products were subsequently manually excluded.  
Remaining compounds and their LELs were then arranged and listed in tables in 
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RESULTS 
NHANES 2003-2004:  
Eight organochlorine pesticides were detected in the serum of the 
participants of the survey and three of them, trans-nonachlor, heptachlor epoxide 
and dieldrin, showed increased odds ratios for ALT elevation across quartiles (p 
trend-adj ≤0.05). The other five pesticides, namely, oxychlordane, 
hexachlorobenzene, hexachlorocyclohexane, dichlorodiphenyldichloroethylene 
(DDE) and dichlorodiphenyltrichloroethane (DDT) showed a trend towards 
significance when we compared the 4th quartile vs. unexposed (95% CI). In the 
4th quartile, DDE had the highest median lipid-adjusted serum concentration 
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ToxRefDB   
At the Lowest Effect Level (LEL), 42 unique pesticides from 474 pesticides 
were associated with steatosis/TASH pathologic descriptors including “fatty 
change”, “Oil red O positive”, “steatosis”, and “lipid deposition”. The 42 
compounds included 22 fungicides, 13 herbicides, 6 insecticides, and 1 miticide 
which are given in Appendix 2, along with study design, species, and LEL values.  
These positive results came from both species (rat = 40 and, mouse = 20) from 
all queried study designs including sub-chronic (n = 16), chronic (n = 34) and 
multigeneration reproductive (n = 10).  Thus, nearly 10% of ToxRefDB pesticide 
studies were associated with the development of steatosis based on the use of 
TASH descriptors. It is possible that, due to the high LEL values associated with 
some reported liver disease descriptors, only a subset of these pesticides are 
consequential to human disease at relevant environmental exposures.  However, 
6 pesticides had LELs less than 10 mg/kg/day, and that increases the likelihood 
that they could be significant mediators of TASH depending on their crop 
application patterns.  These pesticides were: cyproconazole, dazomet, fluazinam, 
hexaconazole, pyrasulfotole metabolite (SXX 0665) and acequinocyl. 
Cyproconazole, dazomet, fluazinam, flusilazole, hexaconazole, paclobutrazol, 
triadimefon, vinclozolin and fluthiacet-methyl pesticides were associated with the 
development of steatosis in more than one study in the ToxRefDB database. This 
reproducibility increases the likelihood that exposures to these chemicals do 
indeed result in TASH. Two fungicides, dazomet and hexaconazole, were linked 
to steatosis in 3 studies and had LELs less than 10 in at least 2 studies. 
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CEBS: 
Three hundred twenty nine studies of 81 chemicals reported positive 
steatosis/TASH descriptors (“toxic hepatopathy” and “fatty change”). These 
chemicals included 31 solvents, plasticizers, monomers, and chemical 
intermediates (Appx. 3), 14 miscellaneous chemicals (Appx. 4), 12 pesticides 
and pesticide intermediates (Appx. 5), 9 fragrances, cosmetics and essential oils 
(Appx. 6), 9 paints, polishes, dyes and food additives (Appx. 7), and 6 PCBs and 
dioxin-like compounds (Appx.8).  Chemical name, study design, species and LEL 
values, when known, are provided. Several chemicals from each class produced 
steatosis with LELs ≤ 10 mg/kg (7/14 pesticides; 6/6 PCBs and dioxin-like 
compounds; 4/31 solvents, plasticizers, monomers, and chemical intermediates; 
3/9 paints, polishes, and dyes; 3/14 miscellaneous chemicals; and 1/9 
fragrances; cosmetics, and essential oils). In CEBS, steatosis was reported in 29, 
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DISCUSSION 
 
In the 2003-2004 NHANES population, an unexpected increase in the 
adjusted odds ratios for ALT elevation was observed in many of the participants. 
ALT levels were the highest in participants with very high serum levels of some 
metals and eight OCPs. Interestingly, among the quartile with the highest ALT 
elevation, the DDE median lipid-adjusted serum concentration was also the 
highest (1535 ng/g) supporting our decision to use DDT and DDE in further 
studies. Along with other compounds in the survey, DDT and OCPs are still 
persistent in the environment. For example, the Blackleaf Chemical site in 
Louisville, Kentucky was reported by the US EPA and the Kentucky Department 
of Environmental Protection to be contaminated with dieldrin, other OCPs and 
metals such as lead and arsenic (48, 49).  
Between CEBS and ToxRefDB, 371 studies linked 123 unique 
environmental chemicals to fatty liver disease in rodents. Pesticides comprised 
almost 44% (54/123) of these chemicals and 14/55 pesticides led to steatosis 
with LELs less than 10. While it is not surprising that insecticides were on the list; 
fungicides and herbicides may be under-recognized mediators of TASH. 
Fungicides and herbicides are widely used at farms, houses and industry (50). 
According to the EPA, annual fungicide consumption worldwide is almost 500 
million pounds (50). Some fungicides such as the conazoles have been 
associated with hepatotoxicity and hepatomegaly in rats (51). Furthermore, 
triadimefon and propiconazole are conazole fungicides that emerged from the 
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ToxRefDB analysis and they have been reported to induce hepatotoxicity and 
hepatomegaly (51). Cyproconazole is another fungicide in the ToxRefDB list 
which is found to cause hepatomegaly, single-cell necrosis and fat vacuolation 
leading to liver damage (52). Moreover, herbicides are widely used in the United 
States. Herbicides are mainly classified into: chlorophenoxy, bipyridil, triazine 
and chloroacetanilide which are also associated in causing or worsening liver 
disease (22). Many of the herbicides from our study do not belong to the 
previously mentioned classes providing researchers new targets for studying liver 
disease. Interestingly, of all pesticides dazomet and hexaconazole were linked 
with fatty liver disease by relatively low LELs in multiple studies. Dazomet is a 
fungicide, herbicide and nematicide that causes hepatomegaly combined with 
large fat droplets due to intermediary- and centro-acinary fatty degeneration in 
mice and it is also associated with liver damage in long term exposure (53, 54). 
Hexaconazole is a systemic triazole fungicide mainly used for control of black 
and yellow sigatoka diseases in bananas (55). Hexaconazole was found to be 
associated with hepatic enzyme elevation, hepatocellular hypertrophy, hepatic 
fatty infiltration and fatty changes in rodent and dog studies (55). While it is not 
surprising that subacute/chronic pesticide exposures resulted in steatosis, it was 
surprising that 10 multigenerational reproductive studies reported a positive 
effect. Additionally, this may be the first evidence linking developmental pesticide 
exposures to fatty liver disease.  
 
 





ACTIVATION OF HEPATIC XENOBIOTIC RECEPTORS BY PESTICIDES 
INTRODUCTION 
 
PXR and CAR were traditionally thought to be xenobiotic detoxification 
receptors but recent studies have demonstrated their roles in glucose and lipid 
metabolism (24, 56).  PXR and CAR also share common ligands and have 
overlapping target gene battery (24). Identifying pesticides that can activate CAR 
and/or PXR is crucial because this can be one of the mechanism(s) by which 
pesticide can exposure cause hepatic fatty infiltration and damage as seen in 
studies in CEBS/ToxRefDB databases. Previous work by our laboratory group 
demonstrated that PCB 153, a known CAR activator, worsened DIO and 
therefore supported the hypothesis that these compounds can also worsen 
NAFLD and DIO through nuclear receptor interaction.  
The ToxCastDB database contains results of high throughput assays that 
test the effect of pesticides on human and rodent receptor activation and target 
gene induction at different doses. Therefore, this database was used to identify 
pesticides that activate CAR and PXR. Furthermore, after identifying pesticides 
associated with NAFLD from the database-screening mentioned in the first part 
of the study, we selected eight pesticides to test for CAR and PXR activation in 
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vitro. The results from this study, supported by information obtained from the 
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MATERIALS AND METHODS: 
ToxCastDB screening: 
The ToxCastDB was established to predict potential toxicity and is a cost-
effective approach for prioritizing thousands of chemicals that need toxicity 
testing (40). The data were collected by the US EPA Office of Pesticide 
Programs (OPP) and the National Center for Computational Toxicology (NCCT) 
and they were released in three different phases (57). As mentioned earlier, 
ToxRefDB was developed from the animal toxicity studies carried out prior to 
pesticide licensure,  compiled as freely accessible and searchable databases 
(41, 57). ToxRefDB was critical in the development of ToxCastDB because it 
contains chemicals of known toxicity profiles from the ToxRefDB database (57). 
ToxCastDB Phase I database contains almost 300 chemicals and phase II 
includes 300 additional compounds, most of which are pesticides (57). The 
pesticides selected to be tested in high throughput assays were compiled from 
previously reported multiple animal toxicity studies. The objective of this process 
was to generate abundant data to form the basis computational predictive 
models of toxicity (57). Importantly, all the ToxCastDB pesticides previously met 
the safety standard for registration (57). Furthermore, the ToxCastDB was used 
to identify compounds associated with PXR activation, utilizing the NGCG, 
Attagene, CellzDirect and Novascreen assays which evaluated chemicals that 
can activate PXR or PXR target gene, CYP3A4. NGCG, Attagene, CellzDirect 
and Novascreen are the sources of the data in the website. The data were 
accessed in 2013 at http://actor.epa.gov/actor/faces/ToxCastDB/Home.jsp. The 
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query was constructed by selecting first ToxCastDB and then “Gene Associated 
with Assays”, leading to a list of genes. For our search purposes, we selected the 
human PXR ATG, NCGC and NVS under the “nuclear receptor subfamily 1, 
group I, member 2” and also the CLZD and NVS under the “cytochrome P450, 
family 3, subfamily A, polypeptide 4”. The hyperlinks in all cases led to tables of 
chemicals that activated the receptor and the gene along with the doses used in 
the studies. 
Compound selection: 
In the NHANES database, dieldrin, trans-nonachlor, DDE and DDT were 
associated with ALT elevation. These pesticides were therefore selected for 
further studies to investigate their interaction with CAR and PXR using transient 
transfection assays. Another candidate, chlordane, was selected because 3 
compounds from the NHANES study namely heptachlor epoxide, trans-nonachlor 
and oxychlordane, are either components or metabolites of chlordane (58). In 
addition to these, we selected 3 more pesticides that are still in the market or 
persistent in the environment. They were selected from the list of compounds 
identified by ToxCastDB, and include lindane, atrazine and alachlor.  
Trans-nonachlor and dichlorodiphenyldichloroethylene (DDE) were purchased 
from SUPELCO (Bellefonte, PA). Lindane and DDT were purchased from CHEM 
Service (PA) and chlordane, atrazine and alachlor were purchased from Sigma 
Aldrich laborchemikal (Tiedel-De Haïn, Seeize). Dieldrin was purchased from 
Sigma Aldrich (St. Louis, MO).  
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Plasmid construction:  
The reporter plasmids for human (h) PXR, were constructed by using two 
copies of a direct repeat 4 (DR4), an inverted repeat 1 (IR1) and a direct repeat 
1(DR1) response element (RE) respectively. The top strand oligonucleotide was 
5’ AGAGTTCATGAGAGTTCATGAGAGTTCATGAGAGTTCATG 3’ for pGL3-
DR4-Luc, 5’ AGAGGTCATTGACCTTTAGAGGTCATTGACCTTT 3’ for pGL3-
IR1-Luc and 5’ AACTAGGTCAAAGGTCAAACTAGGTCAAAGGTCAAA 3’ for 
pGL3-DR1-Luc. The bottom complementary strands had Kpn1 and Xho1 
overhangs at the 5’ and 3’ positions respectively. The oligonucleotides were 
annealed and inserted into Xho1 and Kpn1 restriction sites in the polycloning 
region of a modified version of pGL3 promoter vector (Promega, Madison, WI). 
Reporter plasmid for AhR (pXRE-SV40-Luc) was synthesized using the 
oligonucleotide 5’ TCAGGCATGTTGCGTGCATCCCTGAGGCCAGCC 3’ 
inserted into the EcoR1 site of a modified version of pGL3 promoter vector. 
Expression vector pSG5-hPXR was a generous gift from John Y. Chiang 
(Department of Integrative Medical Sciences, Northeast Ohio Medical University). 
Expression vector pCMV6-hCAR (CAR2) was purchased from Origene 
(Rockville, MD). mPXR was a generous gift from Dr. Steven Kliewer (The 
University of Texas Southwestern Medical Center) and mCAR was a generous 
gift from Tom Rushmore (Merck Research Laboratories, West Point, PA). 
Restriction endonucleases and T4 DNA ligase were purchased from New 
England BioLabs (Ipswich, MA). Dimethyl sulfoxide (DMSO) was purchased from 
Fisher BioReagents (Thermo Fisher Scientific, Pittsburg, PA) and  rifampicin 
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(RIF), androstenol and 6-(4-Chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-
carbaldehyde-O-(3,4-dichlorobenzyl)oxime (CITCO) were purchased from Sigma 
Aldrich (St. Louis, MO). Lipofectamine and Opti-MEM were acquired from Life 
Technologies Inc (Carlsbad, CA). Oligonucleotides were purchased from 
Integrated DNA Technologies (Coralville, IA). 
Cell culture: 
HepG2 Cells: The human hepatoma-derived cell line (HepG2) was 
obtained from American Type Culture Collection (ATCC, Manassas, MD). Cells 
were grown in Dulbecco’s modified Eagle’s medium (DMEM, HyClone 
Laboratories Inc, Thermofisher, Waltham, MA) supplemented with 10% fetal 
bovine serum (FBS) and 1% antimycotic/antibiotic solution (Mediatech, 
Manassas, VA). The cells were incubated in a 5% carbon dioxide atmosphere 
and 95% humidity at 37°C and sub-cultured every 2 days. 
Transfection: 
Cells were plated in Thermo Scientific Nunc 24-well plates and transfected 
at 40-60% confluence. The transfection mix per well contained 150 ng β -
galactosidase expression plasmid (pCMV-β, Stratagene, CA) as a transfection 
control, 50 ng receptor expression plasmid and 150 ng reporter plasmid if not 
otherwise specified. All cells were co-transfected by lipofection using 
Lipofectamine reagent according to the manufacturer’s instructions and Opti-
MEM (reduced serum medium) as the transfecting medium. After 4 hour of 
incubation, the medium was changed to DMEM supplemented with 10% FBS 
and 1% antimycotic/antibiotic solution then cells were left overnight to recover. 
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Compounds of interest were then added to the cells and cells were incubated for 
24 hours. DMSO was used as a vehicle for all compounds (final concentration 
<0.5%). mCAR is constitutively active and therefore its activation was measured 
by the ability of the compound to reverse the inhibition caused by androstenol.  
Reporter assay: 
Cells were washed twice with phosphate buffered saline (1X), harvested 
using 50 µL cell lysis buffer (Promega, Madison, WI) and subjected to a single 
freeze-thaw event.  For β -galactosidase assays, cell extracts (5 µL), were 
incubated with chlorophenol red β -galactopyranoside (CPRG, Roche 
Diagnostics, Indianapolis, IN) at 37 °C for 30-60 minutes. The enzyme activity 
was measured spectrophotometrically at 595 nm using the Bio-Tek Synergy HT 
multi-mode micro plate reader. Luciferase activity assays were performed on cell 
extracts (5 µL) using the Luciferase Assay System (Promega, Madison, WI). 
Luminescence was measured using the Orion L micro plate luminometer 
(Berthold Detection Systems, Pforzheim, Germany) over a 10 second period. 
Receptor activation was measured by luciferase activity and results were 
normalized to the amount of β-galactosidase expressed. 
Statistical analysis:  
All statistical analyses were performed using GraphPad Prism version 
5.01 for Windows (GraphPad Software Inc., La Jolla, CA, USA). Data are 
expressed as mean ± SEM. Multiple group data were compared using One Way 
ANOVA followed by Bonferroni's post-hoc test for parametric data for all pairwise 
comparisons (59). P <0.05 was considered statistically significant. 
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RESULTS 
Identification of pesticides that activate hPXR and induce its target gene 
CYP3A4 (EPA-ToxCast): 
Two hundred eighteen different compounds were found to activate hPXR and 
hPXR target gene CYP3A4 at different doses (Appx. 14). For hPXR activation, 
67 compounds including alachlor, were identified by the NGCG assay (Appx. 9), 
102 compounds including lindane by the Attagene assay (Appx. 10) and  91 
compounds by Novascreen assay (Appx. 11). For CYP3A4 induction, 202 
compounds, including alachlor and atrazine were identified by the CellzDirect 
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Identified chemicals that were mutual among the NHANES, ToxCast, 
ToxRef and CEBS. 
After data-screening of NHANES, ToxCast, ToxRef and CEBS, we clustered the 
results and 30 different compounds were found to be associated with fatty liver 
disease in all the four databases (Table 1). 
Table 1: Mutual chemicals between NHANES, ToxCastDB, ToxRefDB and CEBS 
databases: 
# Chemical Name # Chemical Name 
1.  Bensulide 2.  Metalaxyl 
3.  Buprofezin 4.  Oxadiazon 
5.  Butafenacil 6.  Paclobutrazol 
7.  Chlorpyrifos-methyl 8.  Propiconazole 
9.  Chlorsulfuron 10.  Rimsulfuron 
11.  Cyproconazole 12.  Sethoxydim 
13.  Dimethomorph 14.  Sulfentrazone 
15.  Ethofumesate 16.  Tetramethrin 
17.  Fenarimol 18.  Thiacloprid 
19.  Fipronil 20.  Thiazopyr 
21.  Fluazinam 22.  Triadimefon 
23.  Flusilazole 24.  Triadimenol 
25.  Fluthiacet-methyl 26.  Trifloxystrobin 
27.  Hexaconazole 28.  Triflumizole 
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DDT activates hepatic xenobiotic receptors hPXR, mPXR and hCAR. 
Transient transfection assays of HepG2 cells co-transfected with hPXR or 
mPXR or hCAR were performed for the following pesticides: dieldrin, trans-
nonachlor, lindane, alachlor, chlordane, DDT and DDE, at 10 µM and other 
concentrations to evaluate their interaction with these xenobiotic receptors.  
All compounds except atrazine activated hPXR (dieldrin DDT~2 fold; trans-
nonachlor, chlordane, DDE and alachlor ~1.5 fold; lindane ~2.5 fold). mPXR was 
activated by all the compounds except atrazine and dieldrin (Trans-nonachlor 
and DDT ~2 fold; chlordane and alachlor ~1.7 fold and DDE and lindane ~1.5 
fold) (Figs. 1 & 2).  
hCAR variant 2 was activated by all the compounds except atrazine, chlordane 
and DDE (Alachlor ~1.5 fold; DDT ~1.4 fold and Dieldrin, trans-nonachlor and 
lindane ~1.3 fold) (Fig. 3). On the other hand, mCAR (human variant 1 anthology) 
was not activated by any of the compounds tested (Fig. 4) 
Concentration response relationship was also determined to identify DDT 
and DDE half maximal effective concentration (EC50) for further studies. The 
dose response curve was plotted and the EC50s were calculated using the 
GraphPad Prism version 5.01. DDT was a more potent hPXR activator than DDE 
with an EC50 that was 2.813 µM while the EC50 of DDE was 13.00 µM (Fig. 5&6). 
The results from the in vitro study are summarized in Table 2. 
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Figure 1. Activation of hPXR by pesticides: 
HepG2 cells were co-transfected with pCMVβ, hPXR and pGL3-DR4-Luc and 
exposed to each compound at 10 µM. All compounds except atrazine increased 
the luciferase expression compared to cells exposed to DMSO (solvent control) 
and the highest fold induction was with dieldrin and DDT (~2-fold). Rifampicin (10 






	   29	  
 
Figure 2. Activation of mPXR by pesticides: 
HepG2 cells were co-transfected with pCMVβ, mPXR and pGL3-DR4-Luc and 
exposed to each compound at 10 µM . All compounds except atrazine and 
dieldrin increased the luciferase expression compared to cells exposed to DMSO 
(solvent control) and the highest fold induction was with Trans-nonachlor and 
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Figure 3. Activation of hCAR2 by pesticides: 
HepG2 cells were co-transfected with pCMVβ, hCAR2 and pGL3-DR4-Luc and 
exposed to each compound at 10 µM. All compounds except atrazine, chlordane 
and DDE increased the luciferase induction and the highest fold expression was 
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Figure 4. Activation of mCAR by pesticides: 
HepG2 cells were co-transfected with pCMVβ, mCAR and pGL3-DR4-Luc and 
exposed to each compound at 10 µM with and without 10 µM androstenol. None 
of the compounds increased luciferase expression significantly. Androstenol (10 
µM) was used as a mCAR suppressor and as a negative control and TCPOBOP 
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Figure 5. Concentration response curve of hPXR activation by DDT: 
HepG2 cells were co-transfected with pCMVβ, hPXR and pGL3-DR4-Luc and 
exposed to DDT at concentrations 0.2, 0.5, 1, 2, 5, 10, 20 and 40 µM. hPXR was 
activated at 10 and 20 µM concentrations compared to cells exposed to DMSO. 
Rifampicin (10 µM) was a positive control. The EC50 of DDT was calculated by 
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Figure 6. Concentration response curve of hPXR activation by DDE: 
HepG2 cells were co-transfected with pCMVβ, hPXR and pGL3-DR4-Luc and 
exposed to DDE at concentrations 0.2, 0.5, 1, 2, 5, 10, 20 and 40 µM. hPXR was 
activated at 20 and 40 µM concentrations compared to cells exposed to DMSO. 
Rifampicin (10 µM) was a positive control. The EC50 of DDT was calculated by 
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Table 2. Summary of results of the transient transfection assays: 
 
# Pesticide Name hPXR mPXR hCAR mCAR 
1.  Atrazine - - - - 
2.  Dieldrin + - + - 
3.  Trans-nonachlor + + + - 
4.  Chlordane + + - - 
5.  DDE + + - - 
6.  DDT + + + - 
7.  Lindane + + + - 
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DISCUSSION 
 
Data screening from the three databases; ToxRefDB, CEBS and 
NHANES, highlighted the role of pesticides in NAFLD pathogenesis, therefore, 
inspiring a more detailed investigation into the suggested mechanisms correlated 
with liver disease. We mined the ToxCastDB database that warehouses high-
throughput assays (NGCG, Attagene, CellzDirect and Novascreen), which 
evaluated chemicals that can activate human PXR or induce its target gene, 
CYP3A4. Over 200 compounds activated hPXR or induced CYP3A4. 
Interestingly, some of these compounds are pesticides which are still used in the 
U.S. or banned but persistent in the environment such as alachlor, an herbicide 
used in corn fields, lindane, a pesticide in shampoos for lice, and atrazine, a 
herbicide. Moreover, after screening the databases, 30 chemicals were mutually 
presented (Table 2).  
In the next step of this study, we selected eight pesticides that were 
relevant to human exposure (NHANES) and human PXR activation (ToxCastDB). 
Transient transfection assays to study receptor activation demonstrated that 
almost all the pesticides activated human and/or mouse PXR and human CAR. 
The compounds selected from the ToxCastDB that were hPXR activators were 
further validated in our studies and their activation of hPXR was verified. Our 
results suggest that interaction with PXR might be a crucial molecular 
mechanism for NAFLD development in humans with compounds such as 
dieldrin, trans-nonachlor, lindane, alachlor, chlordane, DDT and DDE, but it might 
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not be with atrazine at the tested dose.  Among the eight compounds studied, 
DDT appeared to be the strongest activator of hPXR, mPXR and hCAR. 
Likewise, DDE, the major metabolite of DDT, also activated hPXR and mPXR. 
Therefore, DDT and DDE were further tested at graded concentrations to 
measure their half maximal effective concentration (EC50); 2.813 µM for DDT 























DDT DID NOT WORSEN NAFLD IN DIET INDUCED OBESITY MODEL 
INTRODUCTION 
The transient transfection experiments indicated that DDT and its major 
metabolites DDE are highly associated with the suggested mechanisms of liver 
disease development, which is consistent with the NHANES report wherein DDE 
reportedly showed the highest Lipid-adjusted serum levels concentration; 1535 
ng/g (Fig. 7). These findings made DDT a good candidate for further evaluation 
























Figure 7. Lipid-adjusted serum levels of organochlorine compounds: 
The median lipid adjusted serum levels of organochlorine compounds detected in 
the 4th quartile of NHANES population showed that DDE had the highest median 
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Both human and animal studies have shown induction of CYP450s by 
DDT, in particular CYP2B and CYP3A (60). DDT induction of P450 is thought to 
be primarily through CAR activation, suggesting that DDT can also exhibit the 
phenobarbital-like hepatic tumor promoting activities as seen in rats and mice 
(60-63).  
DDT is an organochlorine pesticide first discovered by the Swiss 
scientist Paul Hermann Muller in 1939 (64). DDT was used mainly as an 
insecticide to control malaria and typhus and its usage has saved millions of lives 
(64). DDT was banned in the U.S. and many other countries in the early 1970s 
because it was reported in high concentrations in aquamarine animals and it was 
also found to cause sever developmental toxicity to birds (64, 65). However, DDT 
is still used in many African countries to control malaria. DDT is a highly lipophilic 
persistent organic pollutant (65). DDT bio-accumulates in living organisms’ fat 
tissue and hence, it still persists in the environment, and one way of exposure in 
mammals is through breast milk (60). In fact, it has been stated that there is no 
living organism on the planet that is free from DDT (22, 66). 
DDT toxicity is directed mainly to freshwater and marine microorganisms, 
fishes, amphibians and birds (66). DDT residues were found in almost all the 
U.S. great lakes. In fact, DDT was banned in the U.S. in 1972 after many 
investigations, research and reports of the bioaccumulation of DDT and its 
metabolites in toxic levels in birds and aquamarine organisms, such as fish, 
invertebrates, and plants, as a food source for humans and animals. The DDT 
tissue accumulation in the aquamarine organisms was reported in concentrations 
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much higher than those in the physical environment. Studies have also shown 
that DDT use killed aquatic invertebrates in field situations. Therefore, by the 
1960s and 1970s, DDT was known to be significantly prevalent in the aquatic 
ecosystems and in some aquatic animals and plants in the U.S. (65). In addition, 
in 1958, wild birds death took place after DDT applications and when the DDT 
residues were measured in these animals, they were similar to those measured 
in poultry fed DDT containing diet in a study in 1947. DDT levels bioaccumulation 
in birds can be dangerous when DDT and its residue DDD 
(dichlorodiphenyldichloroethane) levels reach 30 ppm or more in the brain. Under 
stress, such as migration, birds mobilize the stored DDT in the fat increasing the 
risk of reaching toxic serum and brain DDT levels. Furthermore, around the 
period when DDT was heavily used, it was reported that the number of Osprey 
birds decreased noticeably in the East Coast nesting colonies. The reported 
decrease in the number of these birds was reasoned to the death of these 
animals as well as the failure of their eggs to hatch due to thin eggshells and 
embryonic death. The phenomenon was also repeatable in laboratory animals. 
Additionally, the increase in the numbers of birds after the reduction and ban of 
DDT application was also reported in may studies. DDT and its metabolites were 
also reported to be accumulated in tissues, such as the brain, liver, adipose, 
muscles and others in mammals including rodents, rabbits, deer, bears and 
others. Moreover, it was also reported that DDT decreases the oxygen evolved 
from the phytoplankton, which are the main source of world’s oxygen (65). 
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Both DDT and DDE are classified by the International Agency for 
Research on Cancer (IARC) as probable Group 2B carcinogens (67). In fact, in a 
clinical trial in Linxian, China, 168 of the trial subjects developed liver cancer, and 
compared to control subjects, they had higher rate of Hepatitis B surface antigen 
(HBsAg) positivity (68). Additionally, DDT is associated with hepatic 
tumorigenesis in mice at higher doses (60). DDT has also been linked to 
neurotoxicity in animals and neonatal exposure in humans affects neurocognition 
(60). DDT was also reported to cause abnormalities in sperm characteristics. 
Furthermore, DDE is antiandrogenic while DDT is estrogenic; however, studies 
found that DDT displays no teratogenic effect (60). 
Technically, DDT is a mixture of 3 main compounds, DDT, DDE 
(dichlorodiphenyldichloroethylene) and DDD; with DDT representing the highest 
proportion of the mixture while both DDE and DDD are DDT metabolites. DDT 
and its major metabolite, DDE, have long half-lives, approximately 7 and 10 
years in humans, respectively (69, 70). Seventy to eighty percent of DDT is 
absorbed in the gastrointestinal tract but this is dependent on the vehicle used. 
DDT metabolism in rodents occurs via two different routes, urinary and hepatic. 
DDA is the major urinary metabolite of DDT while DDE and DDD are the major 
hepatic metabolites (60). The LD50 of DDT in mice reported by ATSDR ranges 
between 152.3 - 1466 mg/kg/day. Different LD50s of DDT in mice were reported 
in different studies and the wide range is reasoned to the use of mice of different 
strains, ages and genders in these studied (71).  
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The purpose of this study is to determine if DDT exposure results in 
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MATERIALS AND METHODS 
Animals and diets: 
The protocol of the animal study was approved by the University of Louisville 
Institutional Animal Care and Use Committee (IACUC). In this 12-week study, 11 
week old male C57Bl/6J mice from the Jackson Laboratory (Bar Harbor, ME, 
USA) were divided into 4 study groups (n=10) based on diet and DDT exposure. 
Mice were fed either a control diet (CD): 10.2% kCal from fat (TD.06416 Harlan 
Teklad) or a high fat diet (HFD): 42% kCal from fat (TD.88137 Harlan Teklad). 
DDT (CHEM Service, PA) was administered on Weeks 3, 5, 7 and 9 by i.p. 
(intraperitoneal) injections in corn oil (vs. corn oil alone) at four individual doses 
of 25 mg/kg (100 mg/kg cumulative). Mice were housed in a temperature and 
light controlled-room (12 hour light/dark) with food and water. Animal weight and 
food consumption were measured every week in this 12-week study. The 
animals were euthanized with sodium pentobarbital (40 mg/kg body weight, i.p. 
injections) at the end of Week 12. Prior to euthanasia, the animals were fasted 
for 6 h (5:00 AM - 11:00 AM) and % fat composition and lean tissue weight were 
measured by a dual energy X-ray absorptiometry (DEXA) scanner (Lunar 
PIXImus densitometer, WI, USA).  
Glucose tolerance test (GTT): 
One week before euthanizing the animals, GTT was performed. On the day of 
the test, mice were fasted for 6 h (5:00 AM - 11:00 AM). A hand-held glucometer 
(ACCU-CHECK Aviva, Roche, Basel, Switzerland) was used to measure the 
fasting blood glucose levels using 1-2 µL blood via tail snip (59, 72). Animals 
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were then injected with 1 mg glucose/g body weight in sterile saline as i.p. 
injections and blood glucose levels were measured at 5, 15, 30, 60, 90 and 120 
min after the injection. 
Liver and white adipose tissue histological studies: 
Liver sections were fixed in 10% buffered formalin for 48 h and then embedded in 
paraffin for histological examinations. The tissues then were sectioned and after 
drying they were then stained with hematoxylin-eosin (H&E). After drying, the 
stained tissues were examined under light microscopy at 10X and 40X 
magnification. Photomicrographs were captured using a Nikon Eclipse E600 
Microscope (59). 
Cytokine and adipokine measurement: 
Plasma cytokine and adipokine levels were measured with the Milliplex Plasma  
Cytokine and Adipokine Kits (Millipore Corp, Billerica, MA, USA) on the Luminex 
IS 100 system (Luminex Corp, Austin, TX, USA), as per manufacturer’s 
instructions. The Piccolo Xpress Chemistry Analyzer using the Lipid Panel Plus 
reagent discs (Abaxis, Union City, CA, USA) was used to measure plasma 
aspartate transaminase (AST), alanine transaminase (ALT), low density 
lipoproteins (LDL), high density lipoproteins (HDL), triglycerides (TG) and total 
cholesterol levels (59). 
Real-time PCR: 
Total RNA was extracted from animal liver tissue samples by homogenizing the 
tissues using the RNA-STAT 60 protocol (Tel-Test, Austin, TX, USA) (59). The 
QuantiTect Reverse Transcription Kit (Qiagen, Valencia, CA, USA) was used to 
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synthesize cDNA from the total RNA (59). Hepatic gene expression was 
measured with StepOnePlus (Applied Biosystems) using Taqman Universal PCR 
Master Mix (Life Technologies, Carlsbad, CA, USA) (59). Primer sequences from 
Taqman Gene Expression Assays (Applied Biosystems, Foster City, CA) were as 
follows: tumor necrosis factor alpha (TNFα) (Mm00443258-m1), fatty acid 
synthase (FAS) (Mm00662319-m1), carnitine palmitoyl transferase 1A (CPT1A) 
(Mm01231183-m1), cytochrome P450s [Cyp4a10 (Mm02601690-gH), Cyp2b10 
(Mm01972453-s1), Cyp3a11 (Mm007731567-m1), CD36 (Mm01135198-m1), 
interleukin 6 (IL-6) (Mm00446190-m1), monocyte chemo attractant protein-2 
(MCP-2) (Mm01297183-m1) and tissue plasminogen activator inhibitor (tPAI-1) 
(Mm00435860-m1) (59). mRNA levels were normalized relative to the amount of 
GAPDH mRNA, and expression levels in mice fed control diet and administered 
vehicle were set at 100% (59). Gene expression levels were calculated according 
to the 2−ΔΔCt method (59, 73). 
Statistical Analysis: 
Statistical analyses were performed using GraphPad Prism version 5.01 for 
Windows (GraphPad Software Inc., La Jolla, CA, USA). Data are expressed as 
mean ± SEM. Multiple group data were compared using two Way ANOVA 
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RESULTS 
 
DDT did not induce obesity in mice fed either CD or HFD. 
 
 
Bodyweights (BW) were measured and the increase in BW with time was 
calculated. The BW gain with time for CD-fed mice was considered 100%. CD-
fed mice did not show an increase in BW with time and this was not affected by 
DDT co-exposure. HFD feeding resulted in an increase in BW with time 
(163.94±4.69%, p <0.001) but this was not affected by DDT co-exposure 
(145.29±5.61%) (Fig. 8). Likewise, HFD feeding resulted in an increase in food 
consumption (kCal/mouse) (43.95±0.99, p<0.001) and this was not affected by 
DDT co-exposure (47.61±0.99) (Fig. 9). 
Fat tissue and lean tissue weight (g) were measured by scanning the animals 
using the DEXA scanning analyses. DDT exposure in CD-fed mice decreased 
the fat tissue weight (6.31±1.085, p=0.027) vs. CD only. HFD feeding increased 
the fat tissue weight in mice (15.68±1.085, p<0.001) but DDT co-exposure had 
no effect (11.56±12.297) (Fig. 10). Neither HFD feeding nor DDT exposure 
affected lean tissue weight in any group (Fig. 11). Epididymal weight/body ratio 
weight (EW/BW) was calculated and HFD feeding increased the EW/BW 
(0.068±0.005, p<0.001) but DDT had no effect on it (0.056±0.006) (Fig. 12). The 
liver weight to body weight ratio (LW/BW) ratio was also calculated and HFD 
feeding increased the LW/BW (0.048±0.002, p=0.022). However, DDT co-
exposure resulted in a decrease in the LW/BW caused by HFD (0.040±0.003, 
p=0.038). There was a significant interaction between HFD and DDT (Fig. 13). 










Figure 8. DDT did not affect body weight gain in either CD- or HFD- fed 
mice: 
CD-fed mice did not show an increase in BW with time and this was not affected 
by DDT co-exposure. HFD feeding resulted in an increase in BW with time (p 
<0.001) and DDT co-exposure did not affect that. The mice weights in the 12th 
week of the study were compared to the initial body weights to calculate the 
percentage of the body weight gain. Data are expressed as mean±SEM and 



















Figure 9. DDT did not affect food consumption in either CD- or HFD- fed 
mice: 
The food consumption (kCal/mouse/week) increased significantly with HFD 
feeding (p<0.001) and it was not affected by DDT co-exposure. The food 
consumption of animals was measured every week during the 12 week study 
then the average of food consumption was calculated and converted into kCal for 
each mouse. Data are expressed as mean±SEM and analysis was performed 



















Figure 10. DDT decreased fat tissue weight in both CD- and HFD-fed mice: 
After 12 weeks, DDT exposure in CD-fed mice decreased the fat tissue weight 
(p=0.027) vs. CD only. HFD feeding increased the fat tissue weight in mice 
(p<0.001) but DDT co-exposure had no effect. The Dual energy X-ray 
absorptiometry (DEXA) scanning analyses was used for measurements and the 
data are expressed as mean±SEM. Analysis was performed using Two Way 

















Figure 11. Neither DDT nor HFD affected the lean tissue weight: 
After 12 weeks, neither HFD feeding nor DDT exposure affected lean tissue 
weight in CD or HFD mice. The Dual energy X-ray absorptiometry (DEXA) 
scanning analyses was used for measurements and the data are expressed as 
mean±SEM. Analysis was performed using Two Way ANOVA and the data 




















Figure 12. DDT did not affect the epididymal weight per body weight ratio in 
CD- and HFD-fed mice: 
HFD feeding increased the EW/BW (p<0.001) but DDT had no effect on it. 
Weights of white adipose tissue were measured after euthanization and the data 
are expressed as mean±SEM. Analysis was performed using Two Way ANOVA. 



















Figure 13. DDT decreased the liver weight per body weight ratio in HFD-fed 
mice: 
HFD feeding increased the LW/BW (p=0.022). DDT co-exposure resulted in a 
decrease in the LW/BW caused by HFD (p=0.038). Weights of livers were 
measured after euthanization and data are expressed as mean±SEM. Analysis 
was performed using Two Way ANOVA. (P<0.05, a: due to HFD, and c: 
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Effect of DDT exposure on liver injury. 
 
Plasma ALT and AST levels were measured using the Piccolo Xpress Chemistry 
Analyzer. The data demonstrated that DDT exposure resulted in decreased 
plasma ALT levels in both the CD- and HFD- fed mice (CD+DDT: 48.80±25.59 
U/L and HFD+DDT: 52.57±30.59 U/L, p=0.048) (Fig. 14). On the other hand, 
neither DDT nor HFD affected plasma AST levels (Fig. 15).  
Steatosis and liver injury were also assessed by H&E staining of liver sections. 
CD-fed group with or without DDT exposure showed no evidence of steatosis. 
However, HFD-fed groups with or without DDT exposure developed steatosis 
with some liver sections. Interestingly, some of HFD-fed mice co-exposed to DDT 
showed less or no steatosis. Additionally, there was no sign of inflammation in 























Figure 14. DDT decreased ALT levels in CD and HFD animals: 
DDT exposure resulted in decreased plasma ALT levels in both the CD- and 
HFD- fed mice (p=0.048). The Piccolo Xpress Chemistry Analyzer was used to 
measure plasma levels of ALT and data are expressed as mean±SEM. Analysis 




















Figure 15. Neither DDT nor HFD affected AST plasma levels: 
Neither DDT nor HFD affected plasma AST levels. The Piccolo Xpress Chemistry 
Analyzer was used to measure plasma levels of ALT and data are expressed as 
mean±SEM. Analysis was performed using Two Way ANOVA and the data 













Figure 16. H&E staining of liver tissues: 
The H&E staining of the liver tissues of CD-fed group with or without DDT 
exposure showed no evidence of steatosis. HFD-fed groups with or without DDT 
exposure developed steatosis, but some of HFD-fed mice co-exposed to DDT 










	   57	  
Effects of DDT on glucose tolerance test (GTT). 
 
Glucose tolerance test  (GTT) was performed one week prior to euthanizing the 
animals. HFD feeding increased blood glucose levels (mg/dL) but this was not 
affected by DDT co-exposure (Fig. 17). Likewise, HFD feeding increased fasting 
blood glucose levels (211.70±9.109 mg/dL, p=0.009) but this was not affected by 
DDT co-exposure (207.57±10.887 mg/dL) (Fig. 18).  
Among the adipokines, plasma resistin levels were not altered in either the CD or 
HFD groups with or without DDT exposure (Fig. 19) whereas HFD groups 
showed increased plasma leptin levels (HFD: 13444.78±1270.850 pg/mL and 
HFD+DDT: 9405.10±1640.660 pg/mL, p<0.001) (Fig. 20). DDT exposure in both 
the CD and HFD mice increased plasma adiponectin levels (CD+DDT: 


















Figure 17. DDT did not affect GTT in either CD- or HFD-fed mice: 
a. HFD feeding increased blood glucose levels (mg/dL) but this was not affected 
by DDT co-exposure at all the time points starting from time 0 and at 5, 15, 30, 
60, and 120 minutes after injecting 1 mg glucose/g body weight. b. The area 
under the curve (AUC) of the GTT. A hand-held glucometer (ACCU-CHECK 
Aviva, Roche, Basel, Switzerland) was used to measure the blood glucose levels 
and data are expressed as mean±SEM. Analysis was performed using Two Way 
ANOVA. (P<0.05, a: due to HFD). 
a. 
b. 











Figure 18. DDT did not affect fasting blood glucose levels: 
HFD groups had high fasting blood glucose levels (p=0.009), but DDT had no 
effect in either CD- or HFD-fed animals. A hand-held glucometer (ACCU-CHECK 
Aviva, Roche, Basel, Switzerland) was used to measure the fasting blood 
glucose levels. Data are expressed as mean±SEM and Two Way ANOVA was 



















Figure 19. Neither DDT nor HFD affected plasma resistin levels: 
Plasma resistin levels were not altered in either the CD or HFD groups with or 
without DDT exposure. Luminex IS 100 system was used to measure the plasma 
levels of resistin. Data are expressed as mean±SEM and Two Way ANOVA was 




















Figure 20. DDT did not affect plasma levels of leptin: 
HFD groups showed increased plasma leptin levels (p<0.001) and DDT had no 
effect. Luminex IS 100 system was used to measure the plasma levels of leptin. 
Data are expressed as mean±SEM and Two Way ANOVA was used for 




















Figure 21. DDT exposure increased plasma levels of adiponectin in CD- and 
HFD- fed mice: 
DDT exposed mice fed CD or HFD had high plasma adiponectin levels (p=0.049) 
compared to unexposed mice. Luminex IS 100 system was used to measure the 
plasma levels of adiponectin. Data are expressed as mean±SEM and Two Way 
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DDT had no effect on plasma cholesterol/triglyceride levels or on 
hepatic/systemic inflammation. 
 
Plasma cholesterol, triglycerides and high density lipoprotein (HDL) levels were 
measured using the Piccolo Chemistry Analyzer. HFD feeding increased plasma 
total cholesterol (HFD: 133.70±7.89 mg/dL and HFD+DDT: 106.5±9.43 mg/dL, 
p<0.001) and HDL levels (HFD: 85.00±7.16 mg/dL and HFD+DDT: 78.60±7.16 
mg/dL, p=0.012) (Fig. 22& 23). On the contrary, HFD feeding decreased plasma 
triglyceride levels (HFD: 43.40±3.945 mg/dL and HFD+DDT: 40.71±4.715 mg/dL, 
p=0.008) (Fig. 24).  
Plasma cytokine levels and their hepatic mRNA levels were measured using the 
Luminex IS 100 system and RT-PCR respectively. HFD feeding decreased both 
plasma IL-6 levels (HFD: 7.74±14.45 pg/mL and HFD+DDT: 19.61±18.65 pg/mL, 
p=0.002) and hepatic IL-6 expression (HFD: 0.60±0.458) and HFD+DDT: 
0.50±5.520, p=0.040) in DDT-exposed and unexposed mice (Fig. 25 &26). On 
the other hand, DDT exposure decreased plasma tPAI-1 levels in both CD and 
HFD groups (CD+DDT: 1285.22±339.512 and HFD+DDT: 951.76±438.301, 
p=0.047) (Fig. 27). Neither HFD feeding nor DDT exposure affected TNFα 
plasma and hepatic mRNA levels (Fig. 28 & 29). Similarly, plasma MCP-1 levels 
and hepatic MCP-2 mRNA levels were unchanged by diet or DDT exposure (Fig. 
30 & 31). The inflammatory cytokines measurements of the unexposed CD-fed 
mice were higher than those of the HFD-fed mice showing that the control group 
mice must had some sort of infection that increased their serum and hepatic 
cytokine levels. 











Figure 22. DDT did not affect total cholesterol plasma levels: 
HFD fed groups had high cholesterol levels (p<0.001) while DDT had no effect. 
The Piccolo Xpress Chemistry Analyzer was used to measure plasma levels of 
total cholesterol and data are expressed as mean±SEM. Analysis was performed 





















Figure 23. DDT did not affect the plasma levels of HDL: 
HFD groups had high HDL plasma levels (p=0.012) while DDT had no effect. The 
Piccolo Xpress Chemistry Analyzer was used to measure plasma levels of HDL 
and data are expressed as mean±SEM. Analysis was performed using Two Way 





















Figure 24. DDT did not affect triglycerides plasma levels: 
HFD fed animals had low plasma levels of triglycerides (p=0.008) while DDT had 
no effect. The Piccolo Xpress Chemistry Analyzer was used to measure plasma 
levels of triglycerides and data are expressed as mean±SEM. Analysis was 




















Figure 25. DDT did not affect IL-6 plasma levels: 
HFD-fed mice had low plasma IL-6 levels (p=0.002) while DDT had no effect. 
Luminex IS 100 system was used to measure the plasma levels of IL-6. Data are 
expressed as mean±SEM and Two Way ANOVA was used for statistical 





















Figure 26. DDT did not affect hepatic IL-6 expression: 
Hepatic IL-6 expression was decreased in HFD fed groups (p=0.040) while DDT 
had no effect. Real-time PCR was used for levels of expression measurement. 
Data are expressed as mean±SEM and statistical analysis was performed using 





















Figure 27. DDT decreased plasma levels of tPAI-1: 
DDT exposure decreased plasma tPAI-1 levels in both CD and HFD groups 
(p=0.047). Luminex IS 100 system was used to measure the plasma levels of 
tPAI-1. Data are expressed as mean±SEM and Two Way ANOVA was used for 
statistical analysis. (P<0.05, a: due to HFD, b: due to DDT effect and c: 





















Figure 28. Neither HFD nor DDT affected the TNFα hepatic expression: 
Neither DDT nor HFD affected the TNFα hepatic expression. Real-time PCR was 
used for levels of expression measurement. Data are expressed as mean±SEM  
and statistical analysis was performed using Two Way ANOVA and the data 





















Figure 29. Neither HFD nor DDT affected TNFα plasma levels: 
Neither HFD feeding nor DDT exposure affected TNFα plasma levels. Luminex 
IS 100 system was used to measure the plasma levels of TNFα. Data are 
expressed as mean±SEM and Two Way ANOVA was used for statistical analysis 
























Figure 30. Neither HFD nor DDT affected MCP-1 plasma levels: 
MCP-1 plasma levels were not affected by either HFD or DDT. Luminex IS 100 
system was used to measure the plasma levels of MCP-1. Data are expressed 
as mean±SEM and Two Way ANOVA was used for statistical analysis and the 



























Figure 31. Neither HFD nor DDT affected hepatic MCP-2 expression: 
MCP-2 liver expression levels were not affected by either HFD or DDT. Real-time 
PCR was used for levels of expression measurement. Data are expressed as 
mean±SEM and statistical analysis was performed using Two Way ANOVA and 
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Effects of DDT on PPARα and LXR target genes. 
 
Hepatic mRNA levels of PPARα target genes, namely carnitine 
palmitoyltransferase I (CPT1a), an enzyme that regulates mitochondrial fatty acid 
beta-oxidation and Cyp4a10, an enzyme that regulates peroxisomal fatty acid 
oxidation were measured (74). DDT exposure resulted in decreased hepatic 
expression of CPT1A mRNA irrespective of the diet type given (CD+DDT: 
0.31±0.110 and HFD+DDT: 0.35±0.131, p<0.001), suggesting that fatty acid 
oxidation was compromised in DDT-exposed mice (Fig. 32). Likewise, hepatic 
Cyp4a10 mRNA expression was lowered in both the DDT-exposed groups 
(CD+DDT: 0.76±0.436 and HFD+DDT: 0.97±0.52, p=0.005). However, HFD 
alone resulted in increased Cyp4a10 mRNA expression (0.77±0.44, p=0.006) 
and there was a significant interaction between HFD and HFD+DDT (p=0.017) 
(Fig. 33).  
Hepatic mRNA levels of liver-X-receptor (LXR) target genes were also evaluated, 
including fatty acid synthase (FAS), an enzyme that catalyzes fatty acid 
synthesis, and CD36, a fatty acid binding protein required for cellular fatty acid 
uptake (75). HFD consumption led to downregulation of hepatic FAS in both 
DDT-exposed and unexposed mice (HFD: 0.40±0.242 and HFD+DDT 0.25±0.29, 
p=0.001) (Fig. 34). On the other hand, DDT exposure in CD-fed mice increased 
hepatic CD36 (2.351±0.598, p=0.031). Likewise, HFD consumption also resulted 
in increased of hepatic CD36 (HFD: 2.518±0.567 and HFD+DDT: 3.925±0.678, 
p=0.017) (Fig. 35). 
 












Figure 32. DDT decreased hepatic expression of CPT1a in both CD- and 
HFD- fed groups:  
DDT co-exposed animals fed either CD or HFD had low expression of hepatic 
CPT1a (p<0.001). Real-time PCR was used for levels of expression 
measurement. Data are expressed as mean±SEM and statistical analysis was 




















Figure 33. DDT decreased hepatic expression of Cyp4a10 in both CD- and 
HFD- fed groups:  
Hepatic Cyp4a10 expression was lowered in both the DDT-exposed groups 
(p=0.005). HFD alone group had in high Cyp4a10 expression (p=0.006) and 
there was a significant interaction between HFD and HFD+DDT (p=0.017).  Real-
time PCR was used for levels of expression measurement. Data are expressed 
as mean±SEM and statistical analysis was performed using Two Way ANOVA. 


















Figure 34. HFD decreased the hepatic expression of FAS:  
HFD-fed groups had low levels of hepatic FAS (p=0.001) while DDT had no 
effect. Real-time PCR was used for levels of expression measurement. Data are 
expressed as mean±SEM and statistical analysis was performed using Two Way 





















Figure 35. DDT and HFD increased the hepatic expression of CD36: 
Hepatic expression of CD36 was increased with DDT (p=0.031) and HFD 
(p=0.017). Real-time PCR was used for levels of expression measurement. Data 
are expressed as mean±SEM and statistical analysis was performed using Two 
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DDT exposure induced Cyp2b10, a CAR target gene. 
 
Hepatic expression of Cyp2b10, a CAR target gene, was measured to determine 
if DDT activated CAR in these animals. DDT exposure led to increased of 
Cyp2b10 in CD-fed mice (83.82±24.474, p=0.026), indicating CAR activation in 
these animals (Fig. 36). Likewise, HFD consumption also resulted in increased of 
Cyp2b10 (73.65±24.474, p=0.049). Interestingly, DDT co-exposure did not 
potentiate Cyp2b10 increased by HFD. Rather, there was a significant interaction 
between HFD and DDT (p=0.036), suggesting that DDT co-exposure in HFD-fed 
mice displayed downregulated Cyp2b10 (HFD+DDT: 42.404±29.252).  
Hepatic expression of Cyp3a11, a PXR target gene, was also measured to 
assess PXR activation in these animals. DDT exposure did not alter Cyp3a11 
expression in CD-fed mice (Fig. 37). However, HFD feeding resulted in increased 
of hepatic Cyp3a11 but DDT had no effect on this (HFD: 5.79±0.803 and 
HFD+DDT: 4.38±0.959, p<0.001). The results indicated that DDT did not activate 



















Figure 36. DDT and HFD increased the hepatic expression of Cyp2b10:  
DDT exposure increased Cyp2b10 in CD- (p=0.026) and HFD- fed mice 
(p=0.049). There was a significant interaction between HFD and DDT (p=0.036). 
Real-time PCR was used for levels of expression measurement. Data are 
expressed as mean±SEM and statistical analysis was performed using Two Way 
ANOVA. (P<0.05, a: due to HFD, b: due to DDT effect and c: interaction between 





















Figure 37. HFD increased the hepatic expression of Cyp3a11:  
HFD increased the hepatic Cyp3a11 expression (p<0.001) while DDT exposure 
did not alter Cyp3a11 expression. Real-time PCR was used for levels of 
expression measurement. Data are expressed as mean±SEM and statistical 
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DISCUSSION 
 
The in vivo study on DDT demonstrated that DDT did not worsen obesity 
or liver injury caused by HFD feeding. However, the DDT-exposed mice 
displayed lower plasma ALT levels, higher plasma adiponectin levels and no 
insulin resistance. DDT exposure also lowered the fat tissue weight in HFD-fed 
mice. Additionally, there was no evidence of either hepatic or systemic 
inflammation observed with DDT exposure. Furthermore, DDT appeared to be a 
CAR activator in our study. These results indicated that DDT exposure appeared 
to be protective from DIO, which is counter-intuitive to our initial hypothesis. 
However, these findings are not surprising, given the fact that CAR activation has 
been closely related to protect against insulin resistance and obesity-related 
disorders (76). In terms of dosage, we used a cumulative dose of 100 mg/kg. 
This was designed to be well below the LD50 of DDT which was reported to range 
from 152.3 - 1466 mg/kg/day to prevent acute toxicity (60). It is possible that 
using a dose >100 mg/kg may have resulted in different outcomes than those 
observed in this study. 
DDT exposure did not affect body weight or food consumption. The 
protective effect of DDT in terms of adiposity was seen in the HFD-fed animals 
that displayed lower fat weight and decreased liver weights. DDT exposure also 
resulted in lower plasma ALT levels. Plasma adiponectin levels were also higher 
in the DDT-exposed mice irrespective of the diet type. Adiponectin is an 
adipokine that regulates glucose and fatty acid catabolism and its levels are 
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inversely proportional to body fat composition. Increased adiponectin levels 
observed in DDT-exposed mice may be a plausible reason for a decrease in fat 
weight in CD-fed mice. Adiponectin also has anti-inflammatory function, which is 
consistent with the absence of inflammation seen in the liver tissues of the DDT-
exposed mice (77). Moreover, DDT exposure also decreased plasma tPAI-1 
levels, confirming the absence of liver injury. DDT exposure did not affect leptin 
levels. Leptin, another adipokine, regulates hunger and satiety and since its 
levels remained unaltered, food consumption was not significantly affected as 
well. Insulin resistance has been linked to high resistin levels in obese mice (78). 
Consistent with our results that showed that DDT did not cause insulin 
resistance, DDT-exposed animals’ plasma resistin levels were not affected. 
DDT exposure did not contribute to elevated plasma cholesterol 
and HDL. Hepatic expression of the lipogenic gene FAS was not affected by 
DDT, indicating that DDT did not cause lipogenesis in these animals. 
Paradoxically, another lipogenic gene, CD36, required for fatty acid uptake by 
cells was increased. CD36 plays an important role in the immune system, 
coagulation cascade, atherosclerosis and lipid metabolism (79). In lipid 
metabolism, CD36 binds HDL, LDL and VLDL and it also works as a scavenger 
for oxidized LDL in macrophages (80, 81). PPARα targets, CPT1a and Cyp4a10, 
were downregulated in DDT-exposed mice indicating that the fat burning 
machinery was compromised in these animals. Surprisingly, this did not cause 
nor worsen steatosis, and one of the reasons could be the protective effects 
exerted by CAR activation. Malabsorption of dietary fat in the HFD+DDT co-
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exposed mice may be another explanation for the absence of steatosis in this 
group. 
DDT induced Cyp2b10 in CD-fed mice, indicating CAR activation 
as mentioned earlier. In contrast, DDT did not activate PXR, since Cyp3a11 was 
not induced. CAR activation is consistent with insulin sensitivity and decreased 
lipogenesis, which is concordant with our findings. The transient transfection 
studies on HepG2 cells mentioned previously demonstrated that DDT did not 
activate murine CAR. However, Mutoh et al showed the ability of phenobarbital to 
activate CAR indirectly through inhibition of the epidermal growth factor receptor 
(EGFR). We speculate that DDT might be acting though the same mechanism as 
phenobarbital to activate CAR indirectly, and this does not necessitate a direct 
ligand interaction (82, 83). CAR activation was also shown to decrease PPARα 
expression and hence, downregulation of its target genes (CPT1a and Cy4a10) 
and this was also observed in our animals (76, 84, 85). In addition, previous 
studies demonstrated that phenobarbital, a CAR activator, downregulated CPT1 
levels in mice but this was not seen in CAR knockout mice, which further 
supports our findings (82).  
Additionally, there was no evidence of either hepatic or systemic 
inflammation observed with DDT exposure or unexposed animals. In fact, the 
measured levels of inflammatory cytokines in the serum and hepatic were higher 
in CD-fed animals, which indicates that these animals had some sort of infection. 
Therefore, they study should be repeated with the unexposed CD-fed animals 
only in order to get valid evaluation of the results from the other groups. Another 
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limitations in this study is that we were using a DIO model to investigate DDT 
hepatic toxicity in mice. However, humans are exposed to different chemicals 
simultaneously. Another alternative approach is to investigate the effects of DDT 
in a mixture of chemicals or using another hit apart from HFD. Choosing a higher 
dose and a more chronic exposure is another potential approach.  
In conclusion, DDT did not decrease body weight or food 
consumption despite downregulation of PPARα target genes. The HFD+DDT 
group of mice also exhibited similar food consumption patterns as HFD group but 
showed lower adiposity. Moreover, DDT did not cause insulin resistance or 
worsen NAFLD. Despite reducing the expression of fatty acids β-oxidation genes, 
DDT improved steatosis in HFD-fed mice. However, DDT did not improve 
diabetes caused by HFD feeding. Furthermore, DDT appeared to contribute to 
these effects through CAR activation. However, further investigation is required 
in terms of CAR direct vs. indirect activation and if using higher doses could 














NAFLD is the most common cause of liver disease worldwide. Toxicant 
associated steatohepatitis (TASH) is a recently identified form of non-alcoholic 
fatty liver disease and it is mainly associated with chemical exposure. However, 
the mechanisms by which environmental chemicals contribute to liver disease 
are not well-studied due to the lack of manifestations and chemical indicators in 
addition to a comprehensive lists of chemicals.  
Three hundred seventy one studies archived in federal databases 
ToxRefDB and CEBS linked 123 unique environmental chemicals to fatty liver 
disease in rodents. Pesticides composed almost 44% of these chemicals. 
Moreover, the compounds found associated with ALT elevation in the 2003-2004 
NHANES were 3 metals and 8 OCPs in addition to more than 200 pesticides 
identified from the ToxCast DB database. Pesticides have been associated with 
NAFLD in many studies and we therefore decided to study the role of some 
pesticides on NAFLD. 
Most of the eight compounds studied activated hPXR, mPXR and 
hCAR and DDT was the strongest activator. Moreover, the main metabolite of 
DDT, DDE, was detected in considerable concentrations in the NHANES 
participants with high ALT levels. Therefore, DDT was selected to be studied in a 
DIO mice model.   
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Upon DDT exposure (12 weeks, 100 mg/kg), Cyp2b10  (CAR target) was 
increased in control diet-fed mice. DDT did not increase Cyp3a11 (PXR target) in 
any group. DDT did not decrease body weight or food consumption, but 
HFD+DDT mice showed lower adiposity. DDT did not cause insulin resistance or 
worsen NAFLD.  
In conclusion, more than 300 environmental chemicals, mostly pesticides, 
were linked to fatty liver disease. The in vivo studies of DDT showed that it 
improved steatosis, but it had no effect on NAFLD, obesity, liver damage or 
diabetes caused by DIO. DDT appeared to contribute to these effects through 
CAR activation. However, further investigation is required in terms of CAR direct 
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Median Concentration Levels and Number of Cases/Total Number) for Pollutant 
Subclasses Lead, Cadmium, and Mercury and Organochlorine Pesticides in Adult 
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* ORs were adjusted for age, sex, race, poverty income ratio, HOMA-IR, and BMI. 
a Median concentration levels. 
b Number of cases / total number. 
c Adjusted odds ratios with 95% confidence intervals. 
† Additionally adjusted for multiple comparisons. 
 
1st quartile: ≤ 25th percentile, 2nd quartile: 25th - ≤ 50th percentile, 3rd quartile: 50th - ≤ 
75th percentile, 4th quartile: >75th percentile. 
 
Abbreviations: CI; confidence interval 
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APPENDIX 2 
Pesticides associated with fatty liver disease in ToxRefDB. 




1. Bromuconazole Mouse-Subchronic 68.1 










4. Diethyl 4,4'-o-phenylenebis (3-thioallophanate) Mouse-Chronic 300 
5. Difenoconazole Mouse-Chronic 819 
6. Dimethomorph Rat-Subchronic 14.2 
7. Famoxadone Mouse-Chronic 274 
8. Fenarimol Rat-Chronic Mouse-Chronic 
14.6 
86 
9. Fluazinam Rat-Chronic Rat-MGR* 
40 
9.7 










12. Iprodione Mouse-Chronic 604 
13. Propiconazole Rat-Chronic 96.4 
14. Metalaxyl Rat-MGR* 62.5 
15. Oxytetracycline hydrochloride Rat-Chronic 1250 
16. Paclobutrazol Mouse-Chronic Rat-MGR* 
113 
62.5 
17. Propanoic acid, 2-(2,4-dichlorophenoxy)-, (R)-  Rat-Subchronic 144 
18. Triadimefon Rat-Chronic Mouse-Chronic 
114 
550 
19. Triadimenol Rat-Subchronic 39.6 
20. Trifloxystrobin Mouse-Chronic 274 
21. Triflumizole Mouse-Chronic 67.4 
22. Vinclozolin Mouse-Chronic Rat-MGR* 
1230 
290 
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Chemicals are arranged according in alphabetic order in each class and their 
LELs are provided according to the screened ToxRefDB studies. 









 23. Bensulide Rat-Subchronic 100 
 24. Butafenacil Rat-Chronic 13 
 25. Chlorsulfuron Rat Chronic 309 
 26. Ethofumesate Rat-Subchronic 1900 









 28. Mesosulfuron-methyl Mouse-Chronic 1360 
 29. Oxadiazon Rat-Chronic 50.9 
 30. Pyrasulfotole metabolite (SXX 0665) Rat-MGR* 9.48 
 31. Rimsulfuron Rat-Chronic 121 
 32. Sethoxydim Mouse-Chronic 41.2 
 33. Sulfentrazone Rat Subchronic 199 
 34. Tepraloxydim Rat-Subchronic 383 
 35. Thiazopyr Rat-Subchronic 201 
Insecticides: 
 36. Buprofezin Rat-Subchronic 316 
 37. Chlorpyrifos-methyl Mouse-Chronic 41.5 
 38. d-cis,trans-Allethrin Mouse-Chronic 350 
 39. Fipronil Rat-Subchronic 19.9 
 40. Tetramethrin Rat-Subchronic 57.9 
 41. Thiacloprid Mouse-Chronic 234 
Miticide: 
 42. Acequinocyl Mouse-Chronic 7 
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APPENDIX 3 
Solvents, plasticizers, monomers, and Chemical Intermediates associated with 
fatty liver disease in CEBS. 
# Chemical Name Study Design and species 
LEL 
(mg/kg) 
1.  2,2-Bis(Bromomethyl)-1,3 propanediol Rat-Chronic 25,000 
2.  4-Vinyl-1-cyclohexene diepoxide Rat-Chronic 50 
3.  4,4'-Thiobis(6-tert-butyl-m-cresol) Mouse-Chronic 250 
4.  Alpha-Methylstyrene Mouse-Chronic 300 
5.  Dibutyl phthalate Rat-Short term 600 
6.  Divinylbenzene Mouse-Chronic 10 
7.  Glycidol Mouse- Short term 100 
8.  Isoprene Rat-Chronic 220 
9.  Resorcinol Rat-Chronic 50 
10.  Sodium selenite Rat-Short Term 4 
11.  Tetrabromobisphenol A Mouse-Short Term 100 
12.  Tetrafluoroethylene Rat-Chronic 156 
13.  Tricresyl phosphate Rat-Chronic 75 
14.  Trimethylolpropane triacrylate Rat-Chronic 0.3 
15.  Vinyl toluene Rat-Chronic Mouse-Chronic 
100 
25 
16.  1-Amino-2,4-dibromoanthraquinone Rat-Chronic 20,000  
17.  4,4'-Diamino-2,2'-stilbenedisulfonic acid, 
disodium salt 
Mouse-Chronic 6250  
18.  p-Nitrobenzoic acid Mouse-Chronic 1250  
19.  p-Nitrotoluene Mouse 1250  
20.  2-Methylimidazole Rat-Chronic 1000  
21.  Methyl isobutyl ketone  Mouse-Chronic 900  
22.  Toluene Rat-Chronic Mouse-Chronic 600  
23.  Barium chloride dehydrate Rat-Chronic 500  
24.  Styrene-acrylonitrile trimer Rat-Short term 250  
25.  Decalin  Mouse-Chronic 100  
26.  3,3'-Dimethoxybenzidine dihydrochloride Rat-Chronic 80  
27.  bis(2-Chloroethoxy)methane Rat-Chronic 75 
28.  1-Bromopropane Mouse-Chronic 62.5 
29.  Tribromomethane Mouse-Chronic 50  
30.  Sodium dichromate dihydrate (VI) Rat-Chronic 14.3 
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mg/L 
31.  1,2-Dihydro-2,2,4-trimethylquinoline 
(monomer) 
Mouse-Short term 3.6  
 
Chemicals are arranged in alphabetic order and their LELs are provided 
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APPENDIX 4 
Miscellaneous chemicals associated with fatty liver disease in CEBS. 
# Chemical Name Study Design and species LEL 
1.  Polysorbate 80 Rat-Chronic 25,000 mg/kg 
2.  T-Butylhydroquinone Mouse-Chronic 1,250 mg/kg 
3.  Benzophenone Rat-Chronic 312 mg/kg 
4.  Cumene hydroperoxide Rat-Short term 100 mg/kg 
5.  Isobutyl nitrite Mouse-Chronic Rat-Chronic  37.5 mg/kg 
6.  N,N-Dimethyl-p-toluidine Rat-Chronic 6 mg/kg 
7.  Sodium azide Rat-Chronic 5 mg/kg 
8.  Tetranitromethane Rat-Chronic 2 mg/kg 
9.  Vanadium oxide Mouse-Chronic 1 mg/M3 
10.  Nickel (II) oxide Rat-Chronic 0.63 mg/m3 
11.  Nickel sulfate hexahydrate Rat-Chronic 0.25 mg/m3 
12.  Indium phosphide Rat-Chronic 0.03 mg/m3 
13.  Gallium arsenide Rat-Chronic 0.01 mg/M3 
14.  3,3'-Dimethylbenzidine dihydrochloride Rat-Chronic 0.003** 
 
Chemicals are arranged in alphabetic order and their LELs are provided 
according to the screened CEBS studies.   
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APPENDIX 5 
Pesticides associated with fatty liver disease in CEBS. 
# Chemical Name Study Design and species 
LEL 
(mg/kg) 
1.  1,2-Dibromo-2,4-dicyanobutane Rat-Chronic 2 
2.  1,2,3-Trichloropropane Mouse-Chronic 6 
3.  1,2,3-Trichloropropane Rat-Chronic 3 
4.  3,3',4,4'-Tetrachloroazobenzene Rat-Chronic 10 
5.  Beta-Picoline Rat-Chronic 312.5 mg/L 
6.  Formamide Rat-Chronic 20 
7.  Fumonisin B1 Mouse-Chronic 80 
8.  Hexachloroethane Rat-Chronic 10 
9.  Monochloroacetic acid Rat-Chronic 10 
10.  Naphthalene Rat-Chronic 10 
11.  p,p'-Dichlorodiphenyl sulfone Mouse-Chronic 30 
12.  Triethanolamine Mouse-Chronic 630 
 
Pesticides are arranged in alphabetic order and their LELs are provided 
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APPENDIX 6 
Fragrances, cosmetics and essential oils associated with fatty liver disease in 
CEBS. 
# Chemical Name Study Design and species 
LEL 
(mg/kg) 
1.  3,4-Dihydrocoumarin Mouse-Chronic 200  
2.  Beta-Myrcene Mouse-Chronic 250  
3.  Dipropylene glycol Rat-Chronic 25,000 
4.  Estragole Mouse-Short term 37.5  
5.  Hydroquinone Rat-Chronic 25  
6.  Isoeugenol Rat-Chronic Mouse-Chronic 75  
7.  Methyl trans-styryl ketone Mouse-Chronic 10  
8.  Methyleugenol Rat-Short term 150  
9.  Tris(2-Chloroethyl) phosphate Rat-Chronic 44  
 
Chemicals are arranged in alphabetic order and their LELs are provided 
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APPENDIX 7 
Paints, polishes, dyes and food additives associated with fatty liver disease in 
CEBS. 
 
Chemicals are arranged in alphabetic order and their LELs are provided 
according to the screened CEBS studies.   










# Chemical Name Study Design and species 
LEL 
(mg/kg) 
1.  2-Butoxyethanol Rat-Chronic 31.2 
2.  2,4-Diaminophenol dihydrochloride Mouse-Chronic 0.038 
3.  Benzyl acetate Rat-Chronic 3,000 
4.  C.I. Acid red 114 Rat-Chronic 0.007  
5.  C.I. Direct blue 15 Rat-Chronic 0.125** 
6.  C.I. Direct blue 218 Rat -Chronic Mouse-Chronic 1,000  
7.  HC yellow 4 Rat-Chronic 25,000  
8.  Malachite green Rat-Chronic 600  
9.  Pyrogallol Rat-Chronic 5 
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APPENDIX 8 
PCBs and dioxin-like compounds associated with fatty liver disease in CEBS. 






1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Rat-Chronic 0.01 
2.  Dioxin mixture Rat-Chronic 10  
3.  PCB 118 Rat-Chronic 0.1 
4.  PCB 126 Rat-Chronic 0.00001 
5.  PCB 153 Rat-Chronic 0.01 
6.  Pentachlorodibenzofuran (PECDF) Rat-Chronic 0.000006  
 
Chemicals are arranged in alphabetic order and their LELs are provided 
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APPENDIX 9 
Pesticides associated Activate hPXR in NCGC-PXR ToxCastDB. 
# Name of Chemical Dose (µM) # Name of Chemical 
Dose 
(µM) 
1.  Alachlor 15.4 2.  Fosthiazate 10.6 
3.  Bensulide 1.57 4.  Hexaconazole 31.2 
5.  Bensulide 1.57 6.  Hexythiazox 18.6 
7.  Bensulide 1.57 8.  Imazalil 36.5 
9.  Bifenthrin 28.4 10.  Indoxacarb 7.96 
11.  Bisphenol A 20.5 12.  Isazofos 5.53 
13.  Buprofezin 5.44 14.  Isoxaben 0.479 
15.  Butachlor 1.95 16.  Metam-sodium hydrate 31.4 
17.  Butralin 36.1 18.  Methoxyfenozide 5.99 
19.  Chlorothalonil 17.7 20.  Metolachlor 0.517 
21.  Clofentezine 11.8 22.  Napropamide 0.479 
23.  Coumaphos 3.74 24.  Oryzalin 7.37 
25.  Cyanazine 6.79 26.  Oxadiazon 5.49 
27.  Cyfluthrin 19.8 28.  Oxyfluorfen 20.8 
29.  Cypermethrin 18.3 30.  Parathion 17.2 
31.  Cyproconazole 23.0 32.  Permethrin 7.57 
33.  Cyprodinil 28.8 34.  Phosalone 11.6 
35.  Allethrin (d-cis,trans) 11.1 36.  Prallethrin 20.0 
37.  DEHP (Diethylhexyl phthalate) 20.8 38.  Prochloraz 6.81 
39.  Dimethenamid 1.42 40.  Prometryn 36.0 
41.  Diniconazole 9.61 42.  Propetamphos 19.1 
43.  Dithiopyr 30.9 44.  Propyzamide 24.1 
45.  S-Bioallethrin 19.2 46.  Pyraflufen-ethyl 33.3 
47.  Endosulfan 10.8 48.  Rotenone 17.0 
49.  Esfenvalerate 27.0 50.  TCMTB 39.0 
51.  Ethalfluralin 14.7 52.  Tebufenozide 21.3 
53.  Ethofumesate 17.1 54.  Tebupirimfos 3.2 
55.  Etoxazole 1.81 56.  Tetraconazole 22.7 
57.  Fenamiphos 28.7 58.  Thiazopyr 1.01 
59.  Fenarimol 20.3 60.  Triadimenol 7.33 
61.  Fenpropathrin 4.59 62.  Tribufos 11.1 
63.  Fipronil 12.6 64.  Triflumizole 32.0 
65.  Fludioxonil 16.1 66.  Triticonazole 4.67 
67.  Flumetralin 1.35      
Chemicals are arranged in alphabetic order. 
 
	   105	  
APPENDIX 10 
Pesticides associated Activate hPXR in ATG_PXR_TRANS ToxCastDB. 
# Name of Chemical Dose (µM) # Name of Chemical 
Dose 
(µM) 
1.  Alachlor 5.7 2.  Fluthiacet-methyl 53.0 
3.  Ametryn 34.0 4.  Flutolanil 34.0 
5.  Azoxystrobin 4.3 6.  Hexythiazox 8.5 
7.  Benfluralin 32.0 8.  Imazapic 51.0 
9.  Bensulide 1.4 10.  Imidacloprid 72.0 
11.  Bensulide 0.56 12.  Indoxacarb 7.3 
13.  Bensulide 0.91 14.  Iprodione 11.0 
15.  Bentazone 47.0 16.  Isazofos 4.5 
17.  Bifenazate 11.0 18.  Isoxaben 1.0 
19.  Bifenthrin 4.1 20.  Lactofen 26.0 
21.  Bisphenol A 14.0 22.  Lindane 22.0 
23.  Buprofezin 3.8 24.  Linuron 40.0 
25.  Butachlor 1.1 26.  Malathion 31.0 
27.  Butralin 7.7 28.  Metalaxyl 14.0 
29.  Carfentrazone-ethyl 43.0 30.  Methoxyfenozide 2.4 
31.  Chlorothalonil 0.22 32.  Metolachlor 6.6 
33.  Chlorpropham 45.0 34.  MGK 18.0 
35.  Cinmethylin 6.6 36.  Molinate 62.0 
37.  Clomazone 35.0 38.  Napropamide 1.3 
39.  Coumaphos 3.9 40.  Oryzalin 2.9 
41.  Cyazofamid 9.4 42.  Oxadiazon 4.9 
43.  Cyfluthrin 25.0 44.  Oxyfluorfen 20.0 
45.  Cypermethrin 10.0 46.  Parathion 24.0 
47.  Cyprodinil 30.0 48.  Pendimethalin 37.0 
49.  Allethrin (d-cis,trans) 11.0 50.  Phosalone 9.9 
51.  Diazinon 33.0 52.  Piperonyl butoxide 15.0 
53.  Dichlobenil 58.0 54.  Pirimiphos-methyl 12.0 
55.  Diclosulam 34.0 56.  Prallethrin 3.6 
57.  
MEHP (Phthalic acid, 
mono-2-ethylhexyl 
ester) 
62.0 58.  Prochloraz 3.6 
59.  DEHP (Diethylhexyl phthalate) 38.0 60.  Prodiamine 5.7 
61.  Disulfoton 38.0 62.  Profenofos 5.0 
63.  Dithiopyr 2.3 64.  Prometryn 25.0 
65.  Diuron 58.0 66.  Propazine 34.0 
67.  S-Bioallethrin 3.6 68.  Propetamphos 7.1 
69.  Esfenvalerate 4.6 70.  Propyzamide 39.0 
71.  Ethalfluralin 17.0 72.  Pyraflufen-ethyl 29.0 
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73.  Ethofumesate 37.0 74.  Resmethrin 23.0 
75.  Etoxazole 3.3 76.  Sulfentrazone 34.0 
77.  Fenamidone 47.0 78.  Tebupirimfos 13.0 
79.  Fenamiphos 14.0 80.  Tetramethrin 43.0 
81.  Fenarimol 49.0 82.  Thiazopyr 0.5 
83.  Fenhexamid 24.0 84.  Thiobencarb 25.0 
85.  Fenitrothion 47.0 86.  Triadimefon 26.0 
87.  Fenpropathrin 11.0 88.  Triadimenol 4.4 
89.  Fenpyroximate (Z,E) 12.0 90.  Tri-allate 25.0 
91.  Fenthion 39.0 92.  Triasulfuron 22.0 
93.  Fipronil 28.0 94.  Tribufos 23.0 
95.  Fludioxonil 23.0 96.  Trifloxystrobin 60.0 
97.  Flufenacet 13.0 98.  Trifluralin 14.0 
99.  Flumetralin 4.3 100.  Triticonazole 10.0 
101.  Flusilazole 36.0 102.  Zoxamide 2.2   
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APPENDIX 11 
Pesticides associated Activate hPXR in NVS_NR_hPXR ToxCastDB. 
# Name of Chemical Dose (µM) # Name of Chemical 
Dose 
(µM) 









7.  Abamectin 18.0 8.  Methamidophos 21.0 
9.  Alachlor 8.6 10.  Methidathion 15.0 
11.  Azinphos-methyl 18.0 12.  Methoxyfenozide 5.9 
13.  
Azoxystrobin 4.7 
14.  Methylene 
bis(thiocyanate) 2.2 
15.  Bensulide 0.62 16.  Metiram-zinc 3.3 
17.  
Bensulide 0.69 
18.  Milbemectin 
(mixture) 6.4 
19.  Bensulide 1.0 20.  Napropamide 0.18 
21.  Buprofezin 5.5 22.  Oryzalin 4.5 
23.  Butachlor 1.3 24.  Oxadiazon 7.5 
25.  Butafenacil 2.4 26.  Pendimethalin 15.0 
27.  
Butylate 47.0 
28.  PFOS 
(Perfluorooctane 
sulfonic acid) 38.0 
29.  Cacodylic acid 15.0 30.  Permethrin 29.0 
31.  Captan 3.5 32.  Phosalone 10.0 
33.  Chlorpyrifos oxon 19.0 34.  Pirimiphos-methyl 9.4 
35.  Clodinafop-propargyl 5.5 36.  Prallethrin 25.0 
37.  Clothianidin 19.0 38.  Prochloraz 5.0 
39.  Coumaphos 6.5 40.  Profenofos 27.0 
41.  Cyclanilide 13.0 42.  Prometryn 13.0 
43.  Cyprodinil 48.0 44.  Propargite 20.0 
45.  Dimethenamid 39.0 46.  Propetamphos 46.0 
47.  Diniconazole 20.0 48.  Propiconazole 14.0 
49.  Dithiopyr 0.31 50.  Pymetrozine 17.0 
51.  Emamectin benzoate 7.1 52.  Pyraclostrobin 7.0 
53.  Ethalfluralin 8.1 54.  Resmethrin 6.6 
55.  Etoxazole 12.0 56.  Spirodiclofen 0.43 
57.  Fenarimol 18.0 58.  TCMTB 1.6 
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59.  Fenhexamid 1.9 60.  Tebupirimfos 35.0 
61.  Fentin 0.86 62.  Tetraconazole 44.0 
63.  Fluazifop-butyl 21.0 64.  Tetramethrin 18.0 
65.  Fluazinam 0.26 66.  Thiazopyr 0.17 
67.  Flufenacet 14.0 68.  Thiobencarb 28.0 
69.  Flumetralin 1.8 70.  Thiodicarb 1.1 
71.  Flumiclorac-pentyl 2.1 72.  Thiophanate-methyl 48.0 
73.  Fluoxastrobin 12.0 74.  Thiram 12.0 
75.  Flutolanil 7.1 76.  Triadimefon 7.6 
77.  Folpet 8.2 78.  Tri-allate 9.7 
79.  Fosthiazate 49.0 80.  Tribufos 40.0 
81.  Hexaconazole 49.0 82.  Triclosan 13.0 
83.  Indoxacarb 3.2 84.  Triflumizole 38.0 
85.  Isazofos 16.0 86.  Trifluralin 28.0 
87.  Isoxaben 0.45 88.  Triflusulfuron-methyl 34.0 
89.  Lindane 27.0 90.  Vinclozolin 6.7 
91.  Malaoxon 33.0    
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APPENDIX 12 
Pesticides associated Activate hPXR target gene CYP 3a4 in CLZD_CYP3A4 
ToxCastDB. 
 
# Name of Chemical Dose (µM) # Name of Chemical 
Dose 
(µM) 
1.  3-Iodo-2-propynylbutylcarbamate 0.58 2.  Imazalil 0.588 
3.  Abamectin 5.65 4.  Imazapyr 1.13 




6.  Imazethapyr 14.1 
7.  Acifluorfen 9.15 8.  Imidacloprid 29.2 




11.  Ametryn 5.21 6.23 12.  Iprodione 
5.77 
13.1 
















18.  Isoxaflutole 6.99 16.1 








22.  Lindane 1.45 4.05 




24.  Linuron 5.44 12.9 
25.  Bensulide 0.783 0.649 26.  Malaoxon 
5.31 
11.3 




28.  Malathion 0.0635 
29.  Bifenazate 0.9 30.  Mancozeb 6.51 




32.  Metalaxyl 8.73 10.4 
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33.  Bisphenol A 3.53 34.  Methidathion 5.26 9.62 
















41.  Butachlor 8.35 42.  Metribuzin 3.95 




44.  MGK 12.2 17.7 








47.  Butylate 0.951 48.  Molinate 6.28 




51.  Carboxin 5.35 8.35 52.  Napropamide 
4.43 
28.3 
53.  Carfentrazone-ethyl 10.3 12.1 54.  Nitrapyrin 0.424 








57.  Chloroneb 0.542 58.  Oryzalin 12.6 12.7 




60.  Oxadiazon 0.568 0.586 
61.  Chlorpyrifos oxon 5.21 7.71 62.  Oxasulfuron 29.2 




65.  Chlorsulfuron 1.69 66.  Oxytetracycline dihydrate 5.35 
67.  Cinmethylin 7.65 12.8 68.  Paclobutrazol 7.6 
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72.  Parathion-methyl 3.61 12.5 
73.  Clomazone 9.04 28.3 74.  Pendimethalin 18.5 















81.  Cyfluthrin 12.3 28.5 82.  Permethrin 2.15 




84.  Phosalone 7.94 




87.  Cyprodinil 28.0 88.  Pirimicarb 6.5 
89.  Cyromazine 5.06 90.  Pirimiphos-methyl 5.24 10.6 












95.  Diazoxon 9.92 29.6 96.  Profenofos 
6.73 
8.97 




99.  Dichlobenil 0.408 100.  Prometryn 7.19 6.98 
101.  Dichloran 6.07 102.  Propanil 12.4 
103.  Diclofop-methyl 10.3 104.  Propargite 1.59 
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109.  




11.9 110.  Propiconazole 
0.533 
2.96 




112.  Propoxur 7.04 8.81 




114.  Propoxycarbazone-sodium 28.0 




116.  Propyzamide 8.7 23.9 




118.  Prosulfuron 6.34 9.19 




120.  Prosulfuron 4.01 4.59 
121.  Dithiopyr 1.29 2.62 122.  Prosulfuron 5.36 
123.  Diuron 5.27 9.37 124.  Pyraclostrobin 4.62 












128.  Pyrimethanil 6.48 9.18 








131.  Ethalfluralin 5.17 13.7 132.  Pyrithiobac-sodium 
10.9 
13.4 
133.  Ethametsulfuron methyl 0.461 134.  Quinoxyfen 9.68 
135.  Ethofumesate 7.0 10.1 136.  Quintozene 3.99 
137.  Ethoprop 4.43 7.0 138.  Resmethrin 4.78 




140.  Rimsulfuron 9.4 
141.  Fenamiphos 5.55 5.77 142.  Rotenone 1.5 
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145.  Fenbuconazole 1.06 2.02 146.  Spirodiclofen 
0.437 
25.6 
















154.  Tebufenpyrad 6.05 24.6 




157.  Fentin 4.0 158.  Tefluthrin 4.5 10.5 
159.  Fipronil 0.568 0.757 160.  Tetraconazole 
0.495 
0.471 
161.  Fluazifop-butyl 12.0 162.  Tetramethrin 3.63 7.09 
163.  Fluazinam 0.475 164.  Thiacloprid 9.55 
165.  Fludioxonil 6.97 9.63 166.  Thiamethoxam 9.18 
167.  Flufenacet 7.59 168.  Thiazopyr 0.547 12.7 




170.  Thidiazuron 5.9 




172.  Thiobencarb 4.47 12.1 












177.  Flumioxazin 4.77 178.  Triadimefon 5.67 5.82 




181.  Fluoxastrobin 0.27 182.  Tri-allate 5.61 
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0.475 7.08 
183.  Flusilazole 0.62 184.  Triasulfuron 4.41 5.91 




186.  Tribufos 0.523 12.5 
187.  Flutolanil 12.1 12.8 188.  Triclosan 4.39 
189.  Forchlorfenuron 28.2 190.  Trifloxystrobin 11.8 12.6 




192.  Trifloxysulfuron-sodium 7.44 
193.  Halosulfuron-methyl 4.54 7.12 194.  Triflumizole 
0.534 
0.764 




197.  Hexazinone 4.37 8.64 198.  Triflusulfuron-methyl 11.8 
199.  Hexythiazox 3.2 3.93 200.  Triticonazole 
1.56 
4.09 
201.  Icaridin 6.82 202.  Zoxamide 4.87 7.55   
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APPENDIX 13 
Pesticides associated Activate hPXR target gene CYP3A4 in 
NVS_ADME_hCYP3A4 ToxCastDB. 
 
# Name of Chemical Dose (µM) # Name of Chemical 
Dose 
(µM) 
1.  HPTE 13.0 2.  Imazalil 0.1 
3.  Bensulide 0.37 4.  Malathion 4.4 
5.  Bensulide 0.49 6.  MGK 3.1 
7.  Bensulide 0.7 8.  Milbemectin (mixture) 9.6 
9.  Chlorothalonil 0.39 10.  Paclobutrazol 4.3 
11.  Cyproconazole 5.7 12.  Piperonyl butoxide 0.95 
13.  Diniconazole 1.3 14.  Tetraconazole 18.0 
15.  Fenarimol 16.0 16.  Triflumizole 0.46 
17.  Fenbuconazole 5.7    
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APPENDIX 14 
Pesticides associated Activate PXR and CYP3a4 in humans in ToxCastDB. 









2.  Imazethapyr 14.1 




4.  Imidacloprid 29.2 72.0 












































13.  Asulam 9.64 14.  Isoxaflutole 6.99 16.1 









17.  Azinphos-methyl 0.493 6.12 18.  Lindane 
1.45 
4.05 















































25.  Bentazone 47.0 26.  Mancozeb 1.5 6.51 
27.  Bifenazate 0.9 11.0 28.  Maneb 0.11 


























34.  Metam-sodium hydrate 31.4 
35.  Bromacil 6.29 36.  Methamidophos 21.0 
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8.82 







































44.  Methylene bis(thiocyanate) 2.2 
45.  Cacodylic acid 15.0 46.  Metiram-zinc 3.3 






49.  Carbaryl 8.42 50.  Metribuzin 3.95 



















56.  Molinate 6.28 62.0 
57.  Chloroneb 0.542 58.  Myclobutanil 6.07 5.24 
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5.93 















62.  Nitrapyrin 0.424 































71.  Clodinafop-propargyl 5.5 28.7 72.  
Oxytetracycline 
dihydrate 5.35 





74.  Paclobutrazol 4.3 7.6 










77.  Clopyralid-olamine 4.87 9.73 78.  Parathion-methyl 
3.61 
12.5 
79.  Clothianidin 19.0 80.  Pendimethalin 15.0 18.5 
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37.0 

























































94.  Pirimicarb 6.5 




















101.  DEHP (Diethylhexyl phthalate) 
20.8 
38.0 102.  Prodiamine 
0.494 
5.65 
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5.7 
13.6 


















109.  Dichloran 6.07 110.  Prometryn 6.98 7.19 
111.  Diclofop-methyl 10.3 112.  Propanil 12.4 





114.  Propargite 1.59 20.0 


































122.  Propoxur 7.04 8.81 








124.  Propoxycarbazone-sodium 28.0 
	   122	  





















128.  Pymetrozine 17.0 




130.  Pyraclostrobin 4.62 7.0 











134.  Pyrimethanil 6.48 9.18 
















138.  Pyrithiobac-sodium 
10.9 
13.4 
139.  Ethametsulfuron methyl 0.461 140.  Quinoxyfen 9.68 





142.  Quintozene 3.99 
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146.  Rimsulfuron 9.4 
147.  Fenamidone 47.0 148.  Rotenone 1.5 17.0 


















152.  Sethoxydim 5.59 27.8 

























159.  Fenoxaprop-ethyl 5.52 160.  TCMTB 1.6 39.0 











163.  Fenpyroximate (Z,E) 12.0 164.  Tebufenpyrad 6.05 24.6 
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167.  Fentin 0.86 4.0 168.  Tefluthrin 
4.5 
10.5 




















174.  Thiacloprid 9.55 





176.  Thiamethoxam 9.18 














180.  Thidiazuron 5.9 
















184.  Thiodicarb 1.1 







187.  Flumioxazin 4.77 188.  Thiram 12.0 




191.  Fluoxastrobin 0.27 192.  Tri-allate 5.61 





































201.  Forchlorfenuron 28.2 202.  Triclosan 4.39 13.0 










205.  Halosulfuron-methyl 4.54 7.12 206.  
Trifloxysulfuron-
sodium 7.44 






















212.  Triflusulfuron-methyl 
11.8 
34.0 
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215.  Icaridin 6.82 216.  Vinclozolin 6.7 








219.  Imazapic 1.13 51.0    
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